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Using NMR to identify structural features of Lin28 regulated miRNAs and 
mRNAs and as a tool for comparing differences in cellular metabolism 
Abstract 
Part 1 of this thesis seeks to identify shared structural features of Lin28- 
regulated miRNAs and mRNAs. Lin28 is an evolutionarily conserved, RNA 
binding protein, highly expressed in stem cells and poorly differentiated cancers, 
that inhibits differentiation and helps maintain stem cell properties. Lin28 binds to 
both the loops of let-7 precursors to block let-7 biogenesis and to Lin28 
responsive elements (LREs) in mRNAs either to enhance or inhibit translation. 
Lin28 RNA binding properties are not well defined. We used NMR spectroscopy, 
fluorescence assays and bioinformatics to identify common features of Lin28 
targets. We show that Lin28 binds G-rich sequences that have properties of G-
quartets (G4s). Based on mutational analysis, we show that G4s are important 
for Lin28 binding.  Upon binding, Lin28 may unwind the G4 structure. Our 
findings suggest that Lin28 recognizes G-quartets in the RNAs it regulates and 
might function to unwind them. 
In part 2 of this thesis we use an unbiased NMR metabolite screening 
method to identify glucose metabolites differentially produced in BPLER and 
HMLER isogenic triple negative breast cancer cell lines that have dramatic 
differences in tumor initiating capacity. N-acetylneuraminic acid (Neu5Ac), a 
iv 
sugar added to the end of glycosylation chains, is much more abundant in 
BPLER than HMLER cells. Manipulating Neu5Ac expression using 
neuraminidase or siRNA knockdown of the Neu5Ac biosynthetic enzymes N-
acetylneuraminic acid synthase (NANS) or cytidine monophosphate N-
acetylneuraminic acid synthase (CMAS), reduces in vitro invasivity of BPLER 
cells. CMAS protein is also increased in BPLER relative to HMLER. 
Overexpressing CMAS in HMLER cells increases their invasiveness. Moreover, 
stable knockdown of CMAS blocks BPLER tumor growth in xenografted mice. 
Thus increased Neu5Ac synthesis is linked to tumor initiation and invasivity in a 
human triple negative breast cancer cell line.  
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Chapter 1: Introduction to Lin28 
 3 
 
The Lin28 protein family regulates networks of RNAs that control 
developmental timing (1-3), pluripotency (4, 5), metabolism (6, 7), and 
tumorigenesis (8-10). Lin28 directly binds to the precursor miRNAs (pre-miRNAs) 
of the let-7 family of miRNAs and to mRNAs that function in maintaining 
pluripotency and regulating cell cycle progression (11-15). How Lin28 selects 
RNA targets remains unclear. Properties of Lin28 binding RNAs have been 
proposed based on mutagenesis analysis, structural studies, molecular modeling 
and sequencing of Lin28-bound RNAs. Uncovering the mechanism by which 
Lin28 selects RNA targets and regulates them is critical to understanding the 
function of Lin28.    
The work in part 1 of this thesis seeks to identify shared structural features 
of Lin28-binding miRNAs and mRNAs that contribute to Lin28 recognition. I will 
first review what is known about the biological role of Lin28 and the identity of its 
targets.  I will then discuss studies to identify the RNA determinants that interact 
with Lin28.  
 
The function of Lin28 
 Lin28 was first identified as a heterochronic gene coordinating the “larva-to-
adult” switch (L/A switch) in C. elegans (1, 2, 16).  In C. elegans, development 
follows a rigid schedule of cell division and differentiation, with four specific and 
well-characterized larval stages (L1-L4). Lin28 expression is highest in the early 
embryo and L1 stage and its expression gradually decreases through L2 and is 
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greatly diminished by L3/L4 stages (3).  Mutant lin-28 worms exhibit severe 
developmental alterations.  Loss of function lin-28 mutations cause precocity, 
where development occurs earlier than normal. Specifically the L2 stage is 
omitted and L3/L4 occurs earlier than in wild-type animals (1).  In gain of function 
Lin28 mutants, worm development is retarded. Early larval stage events, 
including proliferation of lateral hypodermal seam cells, and vulva precursor cells 
and other L2-specific events are reiterated (3).  Thus, proper Lin28 expression is 
a prerequisite for normal development.  
 The Lin28 protein contains the unusual pairing of a cold-shock domain 
(CSD) and two zinc finger (ZnF) motifs (Figure 1.1).  CSDs bind nucleic acids 
and are found in proteins in archea, bacteria and eukayotes (17). ZnFs are often 
found in proteins that bind zinc and interact by finger-like projections with DNA or 
RNA (18, 19). Lin28 is the only animal protein known to contain both a CSD and 
ZnFs. In plants, the Arabidopsis thaliana glycine-rich protein 2 (GRP2) also 
contains both CSD and ZnF domains. GRP2 interacts with G-rich nucleic acids 
and plays a prominent role in flower and seed development (20, 21).  
 Lin28 homologues have been identified in all bilaterian animals. Its 
expression suggests that Lin28 is an evolutionarily conserved regulator of 
differentiation. In Drosophila, Ciona and Xenopus, Lin28 is expressed during 
early embryogenesis, but is not detected in adult animals (22). This same pattern 
is observed in mammals, Lin28 is abundantly expressed in embryos and stem 
cells, but absent in most terminally differentiated cells with the exception of 
skeletal and cardiac muscle (22, 23).  
 5 
 
 
Figure 1.1 Lin28 domain structure. Lin28 protein contains a cold-shock domain 
(CSD) and two zinc finger  (ZnF) motifs. Human Lin28A is 209 amino acids long. 
 
 6 
 In mammals Lin28 has two functionally redundant paralogs, Lin28 (also 
known as Lin28A) and Lin28B. Lin28 is predominately located in the cytoplasm, 
although several studies that use cellular fractionation and immunofluorescence 
microscopy suggest some nuclear localization (24, 25).  Lin28 binds to RNA (22, 
23, 26). Lin28 associates with actively translating mRNAs based on polysome 
profiling (23). Based on pull down experiments, Lin28 forms complexes with 
mRNA binding proteins (26). Mutations in both the CSD and ZnFs lead to nuclear 
accumulation (26). Lin28B contains a nuclear localization sequence and may 
bind to primary let-7 miRNA transcripts (pri-miRNAs) in the nucleus (24).  
In embryonic stem cells (ESCs) Lin28 contributes to pluripotency by 
promoting self-renewal and blocking differentiation (11, 14, 15, 27). Lin28 is part 
of a small unique set of proteins that include OCT4, SOX2, and Nanog that can 
reprogram terminally differentiated fibroblasts to induced pluripotent stem (iPS) 
cells that resemble ESCs (28).  Lin28 is the only protein that is not a transcription 
factor identified thus far to assist in reprogramming. This suggests that Lin28 
targeted RNAs regulate stem cell properties.      
 Genome-wide-association studies (GWAS) have identified single nucleotide 
polymorphisms (SNPs) in Lin28 and Lin28B as genetic factors regulating 
complex traits such as height, onset of puberty, and age of menarche in females 
(29-31). Lin28 transgenic mouse models have also shown many of these traits 
(7). These findings suggest a role for Lin28 in metabolism. In fact, in muscle cells 
Lin28 expression increases glucose uptake via activation of the PI3K-mTOR 
pathway (6, 7). 
 7 
 Lin28 overexpression is associated with many human cancers and is linked 
to poor prognosis (27). Approximately 15% of primary tumors and human cancer 
cell lines have increased Lin28 or Lin28B expression (8, 9, 27, 32).  Elevated 
Lin28 is associated with aggressiveness of germ cell tumors, hepatocellular 
carcinoma, and cancers of the breast, colon, thyroid, esophagus, ovaries, 
prostate and head and neck (8, 9, 33-35). Ectopic Lin28 expression facilitates 
cellular transformation, and Lin28-overexpressing cells can form tumors in mice 
(9). Expression of the Lin28 target let-7 inhibits tumor formation and metastasis 
(36-38).  
 
The Lin28-let-7 interaction 
 Lin28 suppresses the processing of the let-7 family of microRNAs 
(miRNAs) (11, 39, 40). miRNAs post-transcriptionally regulate gene expression 
by suppressing translation and/or accelerating degradation of mRNAs that bear 
partially complementary sequences (41). pri-miRNAs are stem-loop containing 
RNAs that are first processed by Microprocessor, a multi-enzyme complex 
composed of the RNAse III enzyme Drosha and its RNA binding partner DGCR8 
(42, 43) (Figure 1.2). Drosha cleaves pri-miRNAs into ~70 nucleotide (nt) stem-
loop-containing pre-miRNAs that are exported to the cytoplasm, where another 
RNAse III enzyme Dicer removes the loop generating ~22 nt imperfectly paired 
double-stranded RNA duplexes. One strand of the duplex is incorporated into the 
RNA-induced silencing complex (RISC), which binds mRNAs with partially 
 8 
  
 
 
Figure 1.2 let-7 miRNA biogenesis. Primary let-7 miRNAs are transcribed in 
the nucleus and first processed by the RNAse III enzyme Drosha into 70 nt stem-
loop-containing precursor let-7 (pre-let-7) miRNAs.  Pre-let-7 miRNAs are 
exported to the cytoplasm and can be further processed by the RNAse III 
enzyme Dicer into mature let-7 miRNAs that can be loaded onto the RNA- 
induced silencing complex (RISC).  Alternatively, Lin28 can bind the loop 
sequences of pre-let-7s, to recruit TUT4 which uridinylates pre-let-7s (known as 
up-let-7 miRNAs) to promote their degradation (44).  Figure from Heo, I., et al 
(2008).   
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 complementary sequences to induce mRNA decay and/or repress translation 
(41). 
 Humans express 12 let-7 miRNA family members.  Each isoform contains 
identical nucleotides 2-8 in the mature miRNA. This region, known as the “seed 
sequence” (Figure 1.3), defines familes of miRNAs and is important in 
determining target mRNA specificity. miRNAs of the same family regulate 
overlapping, but probably not identical, sets of genes (40).  The let-7 family 
functions as tumor suppressors by down regulating the expression of several 
oncogenes and cell cycle progression genes including c-MYC, HMGA2, RAS, 
cyclin D1 and CDK6 (40, 45). 
 Lin28 binds to the loops of pre-let-7 miRNAs to block let-7 processing by 
Dicer (11-13). The loop sequences are diverse in size and sequence (Figure 1.3) 
Upon binding to let-7 pre-miRNAs, Lin28 recruits ZCCHC11, also known as 
TUTase4 (TUT4), a uridylyl transferase, that adds a 3’uridine tail to pre-let-7s 
(12, 44, 46, 47) (Figure 1.2).  Terminal uridylation blocks Dicer processing and 
promotes pre-let-7 degradation. Although most studies of Lin28 have focused on 
the role of Lin28 regulating let-7, the let-7 miRNAs represent less than 0.05% of 
the RNA that is bound to Lin28 (48).   
 10 
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Lin28-mRNA interactions 
 Lin28 binds to Lin28 responsive elements (LREs) within mRNA targets 
either to enhance or inhibit translation.  In differentiating myoblasts, Lin28 binds 
to the 5’untranslated region (UTR) of IGF2 mRNA to enhance IGF2 translation 
(23). In stem cells, using luciferase reporters, LREs, ranging from 95 nts to 317 
nts in length, were identified in the 3’UTR and coding regions of mRNAs 
associated with pluripotency and cell cycle progression including OCT4, cyclin A, 
cyclin B, CDK4, CDK6, and H2A (14, 15, 49). Lin28 recruits RNA helicase A 
(RHA) to these mRNAs to enhance their translation (50).  RHA is a DEAD-box 
RNA helicase that facilitates RNA-RNA and RNA-protein rearrangements. RHA 
promotes translation of a wide variety of mRNAs with highly structured 5’UTRs 
(50). Sequencing of RNAs bound to Lin28 suggested that Lin28 potentially 
interacts with 1,200 to 13,000 mRNAs (5, 25, 48, 51). How many of these 
mRNAs are actually regulated by Lin28 is unclear.  Various methods have been 
used to experimentally validate Lin28 targets (Table 1.1). Some targets have 
been proposed based on protein levels that change with Lin28 knockdown and/or 
overexpression by western blot (5, 48, 49, 51). Other putative targets have been 
identified by qRT-PCR comparing amounts of mRNAs enriched in a Lin28 
immunoprecipitation (IP) compared to pre-immune IP (5, 49). LREs have been 
verified for some mRNAs by cloning sequence elements into the 3’UTR of 
luciferase reporters (5, 15, 49, 52). Electrophoretic mobility shift analysis (EMSA) 
confirmed Lin28 binding to a subset of targets (48, 52). From these results no 
consistent sequence features of putative LREs has been identified. 
 12 
Table 1.1 List of experimentally validated Lin28 binding RNAs (Continued). 
Chemical shift perturbations of let-7 resonances were monitored with NMR or 
heat exchange with ITC (isothermal titration calorimetry) upon Lin28 addition. 
EMSA (electrophoretic mobility shift analysis) confirmed direct binding of Lin28 to 
RNAs. IP (immunoprecipitation) was used to identify Lin28-bound RNAs in a pull-
down. For many targets the Lin28 recognition mechanism has not been 
determined and is N/A (not available).   
Lin28 
binding 
RNA 
LRE 
 
Lin28 
effect 
Evidence of 
Lin28 binding 
Proposed 
Lin28 
recognition 
mechanism 
Reference 
let-7 
miRNAs 
pre-let-7 
loops 
Inhibits 
miRNA 
processing 
EMSA, 
footprinting, X-ray, 
NMR, ITC, 
molecular 
dynamics, 
fluorescence 
 
3‘GGAG  Viswanathan, S., et al (2008) 
Science 
Newman, M., et al (2008) RNA 
Lightfoot, H.L., et al (2011) 
Biochemistry 
Nam, Y., et al. (2011) Cell 
Loughlin, F.E., et al (2011) NSMB 
Shaik Syed Ali, P., et al (2012) 
FEBS 
Mayr, F., et al (2012) NAR 
Wilbert M., et al. (2012) Mol Cell 
Cho, J., et al (2012) Cell 
 
CD63  Promotes 
translation 
qRT-PCR Lin28 IP N/A Peng, S.,et al (2011) Stem Cells 
CDK4 261 nt 
(3’UTR) 
Promotes 
translation 
qRT-PCR Lin28 
IP, western blot, 
luciferase reporter 
N/A Xu, B., et al (2009) RNA 
Xu, B., et al (2009) NAR 
Cyclin A  Promotes 
translation 
qRT-PCR Lin28 
IP, western blot 
 
N/A Xu, B., et al (2009) RNA 
Xu, B., et al (2009) NAR 
Cyclin B 317 nt  
(1655-
1971) 
Promotes 
translation 
qRT-PCR Lin28 
IP, western blot, 
luciferase reporter 
N/A Xu, B., et al (2009) RNA 
Xu, B., et al (2009) NAR 
DSG2 21 nt 
(5333-
5353) 
N/A EMSA 
 
AAGNNG, 
N is any 
nucleotide 
Cho, J., et al (2012) Cell 
 
E-
Cadherin 
 Inhibits 
translation 
western blot 
 
N/A Cho, J., et al (2012) Cell 
 
EEF1G 330 nt 
(811-
1140) 
Promotes 
translation 
qRT-PCR Lin28 
IP, western blot, 
luciferase reporter 
 
N/A Peng, S.,et al (2011) Stem Cells 
EIF4A  Promotes 
translation 
qRT-PCR Lin28 IP N/A Peng, S.,et al (2011) Stem Cells 
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Table 1.1 List of experimentally validated Lin28 binding RNAs (Continued).  
EpCAM  Inhibits 
translation 
western blot 
 
N/A Cho, J., et al (2012) Cell 
FUS/TLS  Promotes 
translation 
western blot 
 
GGAGA Wilbert M., et al. (2012) Mol Cell 
H2A 125 nt  
(259-393)* 
 tandem 
copies 
Promotes 
translation 
qRT-PCR Lin28 
IP, luciferase 
reporter 
 
A bulge Xu, B., et al (2009) NAR 
HER2 200 nt 
(337-536) 
Promotes 
translation 
Luciferase 
reporter 
 
A bulge Lei, X-X., et al (2011) NAR 
 
HMGA1 129 nt 
(5430671) 
Promotes 
translation 
qRT-PCR Lin28 
IP, western blot, 
EMSA, luciferase 
reporter  
A bulge Peng, S.,et al (2011) Stem Cells 
Lei, X-X., et al (2011) NAR 
hnRNP-F  Promotes 
translation 
western blot 
 
GGAGA Wilbert M., et al. (2012) Mol Cell 
HSPA5 36 nt 
(1019-
1054) 
N/A EMSA, 
 
AAGNG(N), 
N is any 
nucleotide 
Cho, J., et al (2012) Cell 
 
IGF2 1164 nt 
 leader III 
sequence 
Promotes 
translation 
qRT-PCR Lin28  
IP, polysosome 
profiling, 
luciferase reporter 
 
N/A Polesskaya, A., et al (2007) G&D 
 
LAMP1  Inhibits 
translation 
western blot 
 
N/A Cho, J., et al (2012) Cell 
Lin28 3’UTR Promotes 
translation 
western blot, 
luciferase reporter 
 
GGAGA Wilbert M., et al. (2012) Mol Cell 
OCT4 95 nt 
(516-610) 
Promotes 
translation 
qRT-PCR Lin28 
IP, polysome 
profiling, 
luciferase 
reporter, western 
blot 
 
A bulge Qiu, C., et al (2009) NAR 
Peng, S.,et al (2011) Stem Cells 
Lei, X-X., et al (2011) NAR 
RPS13 456 nt 
(33-488) 
Promotes 
translation  
qRT-PCR Lin28 
IP, western blot, 
luciferase reporter 
N/A Peng, S.,et al (2011) Stem Cells 
RPS19 106 nt 
(486-591) 
Promotes 
translation 
Luciferase 
reporter 
 
A bulge Lei, X-X., et al (2011) NAR 
 
SUN1 20 nt 
(1841-
1860) 
N/A EMSA 
 
(N)UGUG(N), 
N is any 
nucleotide 
Cho, J., et al (2012) Cell 
 
TDP-43 85 nt 
(2138-
2222) 
Promotes 
translation 
western blot, 
luciferase reporter 
 
GGAGA Wilbert M., et al. (2012) Mol Cell 
TIA-1  Promotes 
translation 
western blot 
 
GGAGA Wilbert M., et al. (2012) Mol Cell 
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The Lin28 recognition mechanism 
Mutagenesis together with in vitro binding assays has suggested that 
guanine (13, 53, 54), adenine (13), uracil (25), and cytosine (55) residues affect 
Lin28 binding. High-resolution crystal structures of Lin28 bound to pre-let-7 loop 
oligonucleotides suggested the CSD and ZnF domains form critical contacts with 
guanine and adenine bases in distinct G-rich regions in the loops of pre-let-7s 
(Figure 1.4) (54, 56, 57). In particular the ZnF domain was proposed to bind a 
3’GGAG motif in the loop sequence of pre-let-7 miRNAs. However, the NMR 
structure of isolated ZnFs complexed with AGGAGAU suggested that an exact 
GGAG sequence is not required. The authors proposed that the ZnFs bind a 
consensus sequence of NGNNG, where N is any nucleotide (56). Binding and 
structural studies of the isolated Lin28 CSD suggested that the CSD has very 
little sequence specificity since it formed crystals with d(T)6 and r(U)6 (57). 
Sequencing of Lin28-bound mRNAs has led to suggestions that putative Lin28 
consensus sequences might include GGAGA, AAGNNG, AAGNG(N) and 
(N)UGUG(N) where N is any nucleotide (48, 51). A molecular modeling study 
instead suggested that Lin28 recognizes a critical “A” bulge flanked by two G:C 
bonds in an extended double stranded region of the LREs of mRNAs (Figure 
1.5) (52).  A single A to U mutation in mRNAs of OCT4, HMGA1, and RPS19 
inhibited Lin28’s ability to stimulate their translation (52).  Since the “A bulge” is 
not present in pre-let-7 miRNAs, these authors suggested that Lin28 might 
recognize distinct features in its miRNA and mRNA targets. 
 15 
 
 
 
Figure 1.4 Lin28 binding to pre-let-7 elements. The crystal structure of mouse 
Lin28A bound to elements of the pre-let-7 loop sequence (shown in orange) 
suggested that the CSD and ZnF fingers bind critical guanine and adenine 
nucleotides.  The CSD was proposed to bind a GNGAY sequence where N is 
any nucleotide and Y is a pyrimidine.  The CCHC ZnFs were suggested to bind a 
3’GGAG motif.  A three-dimensional model was generated based on the Lin28 
structure bound to the loop of pre-let-7g (PDB ID 3TS2). The schematic for Lin28 
binding is adapted from Nam, Y., et al. (2011). The CSD is in blue, the ZnFs are 
in green, the pre-let-7 loop oligonucleotides are in orange and nucleotides 
extending into the pre-let-7 stem are indicated in yellow.    
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Figure 1.5 A bulge of Lin28 mRNA targets. Lei, X-X., et al (2011) proposed 
that Lin28 binds to a critical unpaired adenine (“A bulge”)  flanked by G:C bonds 
in an extended double stranded region in the Lin28 responsive elements (LREs) 
of mRNA targets. An example is the LRE of OCT4.  
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These structural, sequencing and modeling data have suggested short 
Lin28 recognition elements. Such sequences are abundant in mRNAs throughout 
the transcriptome and hence are unlikely to uniquely define Lin28-binding 
specificity. None of these motifs are useful for predicting LREs of Lin28-regulated 
mRNAs. Thus, the key RNA features that determine Lin28 binding remain 
unclear.  
 
Thesis Objectives: 
The central hypothesis behind this work is that Lin28 regulated miRNAs 
and mRNAs share common structural features. To address this, we analyzed the 
structural features of the pre-let-7s and their loops which contain the 3’GGAG 
motif; the LREs of DSG2, HSPA5 and SUN1, which contain the putative Lin28 
consensus sequences AAGNNG, AAGNG(N), and (N)UGUG(N), respectively; 
and the LRE of OCT4 which contains the proposed “A bulge”. 
We found that pre-let-7 loops and Lin28 recognition elements (LREs) have 
an abundance of guanine and guanine repeats. Because guanine rich nucleic 
acids can form stable planar structures called G-quartets by G:G:G:G hydrogen 
bonding, we hypothesized that Lin28 might recognize structured RNAs that 
contain G-quartets. To examine this hypothesis we used NMR spectroscopy, gel 
shift assays and a dye that specifically binds to G-quartets. We provide evidence 
that a G-quartet structure is important for Lin28 recognition and might be a 
unifying feature of Lin28 RNA targets.   
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let-7 loops and mRNAs with LREs bind to Lin28 by electrophorectic 
mobility shift analysis  
We first confirmed that the pre-let-7s (pre-let-7a and pre-let-7g), the let-7 loops 
(let-7g loop and let-7d loop) and the LREs of DSG2, HSPA5, SUN1 and OCT4 
bind Lin28 by electrophoretic mobility shift analysis (EMSA). 32P-labeled target 
RNAs were incubated with increasing amounts of recombinant mouse Lin28A 
(rLin28A) (Figure 2.1). Gel shifts increased as more rLin28A was added to the 
reaction. Thus, Lin28A directly binds to each of these putative Lin28 targets. A 
32P-labeled miR-21 loop was used as a negative control and even at the highest 
Lin28 concentration did not form a gel shift. 
 
1D NMR spectra of Lin28 binding RNAs contain resonances suggestive of 
non-canonical hydrogen bonds 
We utilized NMR spectroscopy to gain insight into the structural features 
of Lin28 target RNAs. Imino protons are the protons attached to nitrogen 
adjacent to a carbonyl. By monitoring imino protons in nucleic acids, NMR can 
provide information about the hydrogen-bonding network that governs nucleic 
acid structure. Resonances from labile imino protons are only observable when 
they are protected from solvent exchange by hydrogen bonding (Figure 2.2). In 
Watson-Crick base pairing, the imino proton of uracil in an A:U hydrogen bond 
has a chemical shift at ~13 ppm, while the imino proton of guanine in a G:C 
hydrogen bond is closer to 12.7 ppm (1). G:U wobbles and other non-canonical 
hydrogen bonds occur upfield of 12.7 ppm (1-5). For standard A-form RNA or B-
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Figure 2.1 Lin28 directly binds RNA targets.  Electrophoretic mobility shift 
analysis (EMSA)  confirms the interaction between Lin28 and the target 
sequences (pre-let-7a, pre-let-7g, let-7g-loop, let-7d-loop, and LREs of DSG2, 
HSPA5, SUN1 and OCT4). Lin28-RNA complexes are visualized by 
autoradiography as a more slowly migrating band. 32P-miR-21 did not form a 
complex at the highest Lin28 concentration (10 µM).
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Figure 2.2 Watson-Crick and G:U wobble hydrogen bonds. Hydrogen-
bonded imino protons of uracil and guanine (in red)  are protected from solvent 
exchange and are observable by NMR spectroscopy. 
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form DNA, the number of imino resonances correlates with the number of A:U or 
G:C hydrogen bonds.  
Utilizing mFOLD (6), a bioinformatics tool that uses a nearest neighbor 
approach to calculate energy minimized nucleic acid structures, we generated 
predicted secondary structures for the let-7a loop, the let-7g loop, and the LREs 
of DSG2 and OCT4 (Figure 2.3). All these Lin28 targets were predicted to form 
“stem-loop” structures with predominately Watson-Crick base pairing. To probe 
their actual hydrogen-bonding network, we recorded 1D proton NMR spectra for 
each of these Lin28-binding RNAs (Figure 2.4). All of the RNAs had imino 
resonances indicating the presence of hydrogen bonds.  However in addition to 
putative A:U and G:C bonds, each Lin28 RNA target had resonances in the 
region from ~10.0-12.4 ppm indicative of the formation of non-canonical 
hydrogen bonds. 
The observed resonances in this region exceeded the number of predicted 
G:U wobbles based on mFOLD structures (Figure 2.3). This suggests that 
additional unusual hydrogen bonding networks might be present in these Lin28 
RNA targets.  Further, both let-7 loop spectra contain resonance peaks around 
~9.3-9.5 ppm. Resonances in this region have been previously observed when 
guanine or adenine amino protons are shifted downfield due to unusual hydrogen 
bonding found in G:A or A:A mismatches (7) (Figure 2.5). This suggests the 
structure of the let-7 loops contains atypical hydrogen bonds that may include 
G:A or A:A binding. 
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Figure 2.3 Predicted secondary structures of Lin28 targets contain diverse 
stem-loop structures. mFOLD-generated secondary structures for selected 
Lin28 targets including the let-7a loop, let-7g loop and the LREs for DSG2 and 
OCT4.  The length of the stem and the size, number and sequence of the loops 
vary for each target. The number of predicted base-pairs is listed.
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Figure 2.4 Lin28 targets contain non-canonical hydrogen bonds.  The 1D 
imino proton spectra for Lin28 targets (the let-7a-loop, let-7g-loop and the LREs 
for DSG2 and OCT4) contain imino resonances indicative of non-canonical 
hydrogen bonds. The let-7 loop spectra contain unusual peaks at 9.3-9.5 ppm 
(indicated by arrows). Spectra were recorded at 5ºC. 
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Figure 2.5 G:A and A:A hydrogen bonds. The amino proton resonances 
(green) of G:A and A:A hydrogen bonds have characteristic chemical shifts of 
~9.3- 9.5 ppm (7). 
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The LRE of DSG2 is 21 nucleotides long and 48% of the LRE sequence is 
guanine. The DSG2 LRE spectrum contained several broad intense resonances 
from ~10.2-11.4 ppm and an intense peak at 12.3 ppm (Figure 2.4).  When 
DSG2 LRE was concentrated above 500 µM, it formed a gel. Forming gelatinous 
structures at high concentrations has been observed previously for G-rich nucleic 
acids that contain G-quartet structures (8). The 95 nt LRE of OCT4 is longer than 
the other Lin28 LREs we studied. It is also enriched for guanines (30.5%) and 
contains stretches of 2-5 consecutive guanines.  Due to its large size and slow 
tumbling rate, the spectra of OCT4 contains several poorly resolved resonances, 
nonetheless the broad peaks at 10.2-10.8 ppm, 11.6 ppm, and 12.0 ppm suggest 
that the OCT4 LRE also contains non-Watson-Crick base pairs (Figure 2.4).  
Because of the imino resonance pattern and high G-content, we 
hypothesized that these Lin28-binding RNAs might form G-quartets (G4s). G4s 
are composed of four guanines interconnected in a planar configuration through 
cyclic Hoogsteen hydrogen bonding (Figure 2.6). G-rich nucleic acids can form 
stacked G4s that adopt unique structures known as G-quadruplexes (9-11). The 
unusual hydrogen bonding pattern of G4s gives rise to characteristic imino 
resonances at ~10-12.2 ppm (1, 2). Peaks within this region are highly 
suggestive of G-quartet formation.  From our 1D NMR analysis we observed that 
the let-7a loop, let-7g loop, and LREs of DSG2 and OCT4 contain imino 
resonances in this region, suggesting that these Lin28-binding RNAs might 
contain G4 features.   
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Figure 2.6 Hydrogen bonding of G-quartets. G-quartets are composed of at 
least four guanines interconnected through Hoogsteen hydrogen bonds.  A 
monovalent ion (M+)  binds within the central cavity of G-quartets. G-
quadruplexes contain multiple stacked quartets. 
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NMR resonances between 10.2-11.4 ppm in the let-7g loop are 
thermodynamically stable. 
The hydrogen bond network of G4s has increased thermostability and 
slower unfolding rates than standard Watson-Crick base pairs (12).  We therefore 
examined whether the imino frequency resonances corresponding to the putative 
G4-like hydrogen bonds in the let-7g loop were stable as the temperature 
increased (Figure 2.7). By raising the temperature from 10°C-40°C the 
resonances attributed to A:U and G:C pairs disappeared. However the proposed 
G4 resonances at 10.2-12.4 ppm remained intact.  This enhanced thermostability 
provides supporting evidence for the formation of a G4 by the let-7g loop. 
 
Lin28 binding RNAs form higher order oligomers that prevent high-
resolution NMR spectra 
We attempted to use additional multidimensional NMR methods, such as 
Nuclear Overhauser Effect spectroscopy (NOESY), to unambiguously map the 
hydrogen bond connectivity of Lin28-binding RNAs.  The cross peaks in a 
NOESY spectrum connect resonances from nuclei that are located within close 
proximity (~5 Å) (13).  However despite adjustments to buffer, concentration, 
temperature, counter ions and pH, the resonances in NOESY spectra for Lin28-
binding RNAs remained poorly defined, making the spectra difficult to interrupt.  
A representative NOESY spectrum from the let-7g-loop is shown in Figure 2.8. 
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Figure 2.7 The G-quartet-like bonds of let-7g loop are thermodynamically 
stable. 1D proton spectra of the let-7g-loop at 10°C, 20°C, 30°C and 40°C 
indicate the proposed G-quartet hydrogen bonds have increased stability 
compared to A:U and G:C bonds whose resonances disappear at 40°C.   
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Figure 2.8 1H-1H NOESY of let-7g loop. The NOESY spectra for many Lin28 
targets contain weak NOES with very poor resolution.  Alterations in buffer, 
concentration, pH, temperature and counter-ion concentrations did not 
significantly improve spectra. Shown is a representative 1H-1H NOESY spectrum 
of  let-7g-loop (A) and close up of the imino region (B).  
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Because of the poor spectral resolution, Lin28-binding RNAs may oligomerize 
and/or dynamically change structure in solution.  To examine this possibility, we 
analyzed the Lin28-binding RNAs by denaturing and native polyacrylamide gel 
electrophoresis (PAGE) (Figure 2.9). The Lin28 targets migrated as a single 
species on a denaturing gel when heated and denatured by adding 8 M Urea. 
However, when the same RNAs were electrophoresed under non-denaturing 
conditions, they formed multiple bands suggestive of higher order oligomers.  
Multiple bands persisted when the RNA concentration ranged from 0.05-10 µM. 
RNA multimers can also be sensitive to composition and concentration.  Addition 
of Na+, K+, Li+ or Mg2+ chloride salts did not affect the migration pattern.  Thus, 
Lin28 targets may form multiple species.  Since NMR requires high 
concentrations of a single RNA species to obtain quality spectra, the formation of 
multiple species in solution likely was responsible for the poor quality NOESY 
spectra. 
 
Lin28-binding RNAs bind the G4-specific dye N-methyl mesoporphyrin IX 
N-methyl mesoporphyrin IX (NMM) is a dye that binds selectively to G4s 
(14-17) (Figure 2.10). Based on the structure of NMM bound to human telomeric 
DNA, the large planar surface of the porphyrin ring of NMM interacts in parallel 
with planar G-quartets (14, 15). When it binds to G4s, NMM is excited at 399 nm 
and fluoresces at 614 nm (17). We therefore compared NMM fluorescence of 
Lin28-binding RNAs (pre-let-7a, let-7a loop, let-7g loop, let-7d loop, and the 
LREs of DSG2, HSPA5, SUN1 and OCT4) with that of RNAs that lack a G4  
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Figure 2.9 Lin28 RNAs migrate as multiple bands. PAGE analysis under 
denaturing conditions (heat and 8 M Urea)  and native conditions (A). In (B) 
RNAs were analyzed at concentrations ranging from 0.05-10 µM (left)  and at 
1µM concentration with the specified concentrations of counter ions (right). RNAs 
of 25, 21 and 17 nt were used as markers (M). RNA was visualized using SYBR-
gold staining. 
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Figure 2.10 N-methyl mesoporphyrin IX structure. N-methyl mesoporphyrin IX 
(NMM) is a fluorescent dye that selectively binds to the planar structure of G-
quartets (14-17).  
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structure. Strong NMM fluorescence was measured for the known G4 RNA 
UG4U (UGGGGU) and for all of the Lin28-binding RNAs measured, but little to 
no fluorescence was detected when NMM was mixed with yeast-tRNA, polyU or 
the loop of miR-21 (Figure 2.11). SUN1, which had weakest affinity for Lin28, 
based on the Lin28 concentration needed to observe a gel shift (Figure 2.1), also 
had the least NMM fluorescence. Thus Lin28 affinity may correlate with NMM 
fluorescence. A higher molar concentration of let-7 miRNAs than LRE RNA was 
needed to saturate NMM fluorescence. Taken together with the 1D NMR results, 
NMM fluorescence suggests that Lin28-binding miRNAs and mRNAs form G4s. 
 
RNA mutations that disrupt Lin28 binding disrupt NMM fluorescence 
To probe further whether Lin28 binding correlates with NMM binding, and 
presumed G4 formation, we generated RNAs that were truncated or contained 
mutations that might affect G4 formation.  For the let-7g loop we mutated C18C19 
to U18U19 (C-Mt), G27G28 to A27A28 (G-Mt1) and G4G5 and G27G28 to A4A5 and 
A27A28 (G-Mt2). We also synthesized a HSPA5 LRE truncation by removing 9 nt 
from the 5’end containing the first two GG-repeats (HSPA5-tr). We tested the 
ability of each mutant to bind Lin28 by EMSA and to bind to NMM by 
fluorescence assay (Figure 2.12). Compared to the wild-type let-7g-loop, the C-
Mt had increased affinity for Lin28 as suggested by the relative intensity of the 
gel-shifted band with that of free let-7g loop and increased NMM fluorescence.  
G-Mt1 had reduced Lin28 binding and weaker NMM fluorescence. G-Mt2 did not 
bind to Lin28 and showed no NMM fluorescence. HSPA5-tr did not cause a Lin28 
gel shift or NMM fluorescence, suggesting that G-repeats are critical for 
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Figure 2.11 Lin28-binding RNAs bind NMM. NMM is a dye that binds G4-
containing nucleic acids and then  fluoresces at 614 nm (17). NMM was 
incubated with increasing concentrations of RNA.  In (A) are mRNA LREs and 
(B) depicts let-7 targets.  PolyU, tRNA and the miR-21 loop did not bind NMM.
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Figure 2.12 Lin28 binding correlates with NMM fluorescence. (A) let-7g loop 
mutations and HSPA5 truncation evaluated for gel shift and NMM binding. 
EMSAs comparing the Lin28 interaction with wild-type and mutant let-7g loop (B-
D) and full length and truncated HSAP5 LRE (E). NMM fluorescence assay for 
wild-type and mutant let-7g loop and full length and truncated HSPA5 LRE (F). 
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Lin28 binding and that Lin28 binding correlates with NMM fluorescence. These 
findings suggest that Lin28 and NMM recognize a shared structural feature of 
RNA.  Since NMM is only known to bind G-quartets, Lin28 likely recognizes a G4 
structure in its targets. 
 
Lin28 mRNA target datasets are enriched for sequences with the potential 
to form G4s 
We next utilized bioinformatics to determine if a G4 structure might be a 
unifying theme among a larger group of Lin28 RNA targets. QGRS (Quadruplex 
G-Rich Sequence) Mapper predicts G4s in nucleic acids by identifying potential 
G-quartet sequences that match the following motif: GxNy1GxNy2GxNy3Gx, where x 
is the number of G-repeats and y1,y2,y3 are the length of the gaps (18). The 
program generates a G-score such that sequences with higher scores are more 
likely to form G4s.  
To determine if Lin28 binding RNAs are enriched for sequences with the 
potential to form G4s we compared G-scores of Lin28 targets including the Peng 
dataset of Lin28-bound mRNAs identified in human embryonic stem cells that 
were at least 2.5-fold enriched in a Lin28 immunoprecipitation (IP) as compared 
to pre-immune control IP (19) and the Hafner dataset of Lin28-bound mRNAs 
that were identified by Photoactivatable-Ribonucleoside-Enhanced Crosslinking 
and Immunoprecipitation (PAR-CLIP) in FLAG/HA-Lin28 overexpressing HEK 
293 cells (20) to G-scores of other classes of mRNAs (Figure 2.13). FMRP 
(Fragile-X-mental-retardation protein-1) binds mRNAs that contain G4s (21-23). 
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 Figure 2.13 Lin28-binding mRNAs are predicted to form G4s. Cumulative 
distribution plot of G-scores generated by the G4 prediction tool QGRS Mapper 
(18).  Sequences with higher G-scores are more likely to form G4s. FMRP target 
mRNAs form G4s (20-22) and FMRP mRNA targets (green) have increased G-
scores compared to random mRNAs (black) (p < 0.05). HUR binds AU-rich 
mRNAs (23), and HUR mRNA targets (blue) have decreased G-scores 
compared to random mRNAs (p < 0.005).  The top 50 enriched Lin28-bound 
mRNAs (red) in the Peng dataset of Lin28 targets (19)  have significantly 
increased G-scores compared to random mRNAs (p < 0.005). The top 50 Lin28 
mRNA targets in the Hafner dataset identified by PAR-CLIP (orange) (20) had 
higher G-scores than random mRNAs (p < 0.05).   P-values were calculated 
using a Kolmogorov-Smirnov (K-S) test.  
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We therefore selected the top 50 enriched FMRP mRNA targets to test the 
algorithm. The G-scores of HUR target mRNAs were used as a negative control 
for predicting G4s as HUR is known to bind AU-rich mRNAs (24).  We also 
calculated G-scores for 50 random mRNAs. As expected, FMRP-binding mRNAs 
had significantly higher G-scores than random mRNAs (p = 0.017) and the HUR 
mRNAs had significantly lower G-scores than the random mRNAs (p < 0.0001) 
(Figure 2.13). The top 50 enriched Lin28-bound mRNAs in the Peng dataset (19) 
had significantly higher G-scores than random mRNAs (p < 0.0001). The top 50 
Lin28 target mRNAs from the Hafner dataset also had higher G-scores than 
random mRNAs (p = 0.017). The top 50 Peng Lin28-binding mRNAs also had 
significantly higher G-scores than the FMRP target mRNAs (p = 0.004). Thus 
Lin28-binding RNAs are highly enriched for sequences predicted to form G4s. 
The increased G-score of Lin28 mRNAs from multiple target datasets supports 
our hypothesis that a common feature among Lin28-binding RNAs might be the 
ability to form G4s.  
  
Lin28 binds GGA-repetitive G4s 
We next evaluated whether Lin28 binds to other G4 containing nucleic 
acids. UG4U, the thrombin binding aptamer (TBA) and d(GGA)8 all contain G4s 
that form distinct quadruplex structures (Figure 2.14).  UG4U is an 
intermolecular quadruplex formed by 4 separate strands coming together to 
create 4 stacked G4s in parallel (25), TBA (d(GGTTGGTGTGGTTGG)) forms a 
chair type anti-parallel quaduplex with two stacked G4s (26) while d(GGA)8 is 
unique, in that its structure contains both a G-quartet (G:G:G:G) and a mixed 
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Figure 2.14 G-quadruplexes form diverse structures. Known quadruplexes 
UG4U with sequence UGGGGU, the thrombin binding aptamer (TBA) with 
sequence d(GGTTGGTGTGGTTGG) and d(GGA)8 form distinct conformations 
based on the number of stacked G4s, loop sequences and whether they are 
formed by inter- or intramolecular G4s.  
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(G:A:G:A:G:A:G) heptad plane (27). GGA-repetitive quadruplexes like d(GGA)8 
can also form A(G:G:G:G)-pentad and A(G:G:G:G)A-hexad structures (28-30). 
As expected UG4U, TBA and d(GGA)8 all exhibit strong NMM fluorescence. 
However, despite NMM binding, only d(GGA)8 bound to Lin28 by EMSA (Figure 
2.15).  Thus, Lin28 does not bind to all nucleic acids that contain G4s. However, 
we wondered whether a structural feature of d(GGA)8 might facilitate its 
interaction with Lin28. Sequence comparison of Lin28 binding RNAs with 
d(GGA)8 demonstrated that multiple GGA-rich tracts are present in Lin28 target 
sequences, although sometimes the order of As and Gs is reversed. In addition, 
the 5’terminal 28 nt sequence of the HSPA5 LRE is nearly identical to d(GGA)8 
(Figure 2.16). 
 
Experimentally validated Lin28-binding RNAs are enriched for G-repeats 
For each Lin28 target with an experimentally defined LRE, we calculated 
the frequency of each base and tabulated the number and length of G-repeats, 
GGA-repeats and AGG-repeats in each LRE (Table 2.1). Most LREs are 
enriched for guanines (average 30%) and have multiple stretches of 2-6 
consecutive guanines and at least one GGA- or AGG-repeat. The frequency of G 
was not enhanced mostly for the longer LREs (200-3270 nt), which may not 
correspond to the minimal LRE sequence. G-repeats are under-represented 
compared to repeats of other bases in exon sequences (31) (Table 2.2). 
Although the overall frequency of bases within exons is relatively the same for G, 
C, A, and T, searching for the pattern (X3+N1-7X3+N1-7X3+N1-7X3+) for X=G, C, A,T 
and N is any nucleotide showed about half as many G-repeats than repeats of 
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Figure 2.15 Lin28 does not bind all G4 containing nucleic acids. (A) NMM 
fluorescence assay confirming that UG4U, the thrombin binding aptamer (TBA) 
and d(GGA)8 form G-quartets. (B-D) EMSAs indicating that Lin28 does not bind 
to UG4U (B) or the thrombin-binding aptamer (C), but does form a complex with 
d(GGA)8 (D).
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Figure 2.16 Lin28-binding RNAs have sequence similarities to GGA-
repetitive G4s. (A) Individual clustalw sequence alignments highlighting the 
sequence similarity between d(GGA)8 and selected Lin28-binding RNAs. 
Conserved nucleotides are shown in red and purine substitutions are shown in 
orange. 
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Table 2.1 LREs are enriched for guanine (Continued). The frequency of each 
base (A, U, G, C) was calculated for LREs of Lin28-binding RNAs with a defined 
LRE. The most enriched nucleotide is shown in red.  The number and length of 
G-repeats, GGA-repeats, and AGG-repeats was also tabulated.   
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Table 2.1 LREs are enriched for guanine (Continued). 
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Table 2.2 Frequencies of bases and patterns within exons.  Frequency of 
each base in human exonic regions.  The observed pattern refers to the 
frequency of the pattern, X3+N1-7X3+N1-7X3+N1-7X3+ for X = G,C,A,T and 
normalized to 1 for X=T.  Table from Huppert, J.L., et al. (2005).   
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other bases (31). Evolutionary pressure may have disfavored G-repeats to 
prevent G4 structures in transcribed RNAs (31).  Thus the high frequency of G-
repeats in Lin28 targets is unusual. Compared to the exon frequency rates, the 
striking increase of G-repeats within Lin28-binding RNAs suggests that G-
repeats are not a result of random chance, but may have evolved to have a 
functional role. 
 
C. elegans pre-let-7 binds N-methyl mesoporphyrin IX and contains GGA-
repeats  
Many Lin28-binding RNAs are evolutionarily conserved, as best 
exemplified by the let-7 family of miRNAs, which are present throughout the 
animal phyla (32). To ascertain if the G4 structure is evolutionarily conserved, we 
synthesized the C. elegans pre-let-7 miRNA (cel-pre-let-7) and tested its ability to 
bind NMM (Figure 2.17). cel-pre-7 induced modest NMM fluorescence, while 
tRNA, polyU and the miR-21 loop did not.  In addition, like other Lin28-binding 
RNAs, cel-pre-let7 contains several GGA repeats (Figure 2.17).  Although further 
studies are required, the ability of cel-pre-let-7 to bind NMM suggests that G4 
features might be an evolutionarily conserved structural mechanism for Lin28 
recognition.   
 
Lin28 binding disrupts the ability of Lin28 RNA targets to interact with N-
methyl mesoporphyrin IX 
Upon binding, Lin28 induces a conformational change in its RNA targets (33-36). 
We hypothesized the Lin28-induced RNA rearrangement might unwind the RNA
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Figure 2.17 C. elegans pre-let-7 binds NMM and contains GGA repeats. (A) 
NMM fluorescence assay indicates that the C.elegans pre-let-7 miRNA (cel-pre-
let-7) binds NMM, while yeast tRNA, polyU and the miR-21 loop do not. (B) 
Clustalw sequence alignment of cel-pre-let-7 and d(GGA)8 showing that cel-pre-
let-7 contains several GGA repeats. Conserved residues are highlighted in red, 
purine substitutions are shown in orange.  
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G4 structure. To test this idea we performed a modified NMM assay in which the 
let-7g-loop or HSPA5 LRE were incubated with a constant concentration of NMM 
and increasing amounts of rLin28A or bovine serum albumin (BSA) (Figure 2.18) 
The let-7g-loop and HSPA5 LRE exhibited strong NMM fluorescence on their 
own, but when Lin28 was added, NMM fluorescence was lost. Addition of BSA 
had no effect. Thus, in the presence of Lin28, the RNA targets are no longer able 
to interact with NMM.  These results suggest that Lin28 competes with NMM 
binding or that Lin28 binding unwinds the G4s, abrogating NMM binding. 
 
N-methyl mesoporphyrin IX inhibits Lin28 binding to target RNAs via EMSA 
By binding to G4s within gene promoters and within regulatory sites of 
mRNAs, G4 intercalating agents, like NMM, inhibit transcription and translation 
(37-39). We performed a competition EMSA to examine whether NMM inhibits 
Lin28 binding (Figure 2.19). Both 32P-labeled let-7g-loop and HSPA5 LRE bound 
rLin28A as measured by the presence of a gel shift. However, adding increasing 
amounts of NMM led to a decrease in the gel shift and an increase in the signal 
of free RNA. Thus NMM inhibits Lin28’s ability to bind RNA. To our knowledge 
this is the first example of a small-molecule inhibitor of Lin28 binding. The miR-21 
loop and HSPA5 LRE truncation (HSPA5-tr) did not bind Lin28 or NMM at the 
highest concentration.  
 56 
 
 
 
 
Figure 2.18 Lin28 binding inhibits NMM fluorescence. 50 µM of the let-7g-
loop or HSPA5 LRE  were incubated with a constant amount of NMM (5 µM). 
When increasing amounts of rLin28A were added, NMM fluorescence 
diminished. BSA had no effect. Lin28 or BSA on their own did not fluoresce.  
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Figure 2.19 NMM inhibits Lin28 binding. Competition EMSAs for Lin28 binding 
to the let-7g-loop (A) and HSPA5 (B). 32P-labeled RNAs were incubated with a 
constant amount of rLin28A (10 µM) known to form a Lin28•RNA gel shift. 
Increasing amounts of NMM (0-100 µM) diminished the amount of rLin28A 
shifted product and increased signal of the free 32P-RNA. NMM and rLin28A had 
no effect on miR-21 or HSPA5-tr.   
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Materials & Methods: 
Lin28 expression and purification 
The cDNA for mouse Lin28A were obtained from Addgene (Cambridge, MA). 
The region containing the CSD and ZnFs (residues 36-186) was PCR amplified 
and cloned into the bacterial expression vector pET15b, adding a C-terminal 
HIS6 tag. Lin28-HIS6 was overpressed in E. coli Rosetta (DE3) cells (Millipore).  
Cells were grown in Luria Broth (LB) medium at 25°C to an OD600 of 0.9 and 
induced with 1.0 mM isopropyl D-1-thiogalactopyranoside (IPTG). After 3 hours, 
cells were harvested by centrifugation.  Cells were lysed by sonication in 50 mM 
Tris-Cl pH 8.0, 1M NaCl, 5 mM β-mercaptoentanol (BME), 0.1 mM ZnCl2 and 10 
units of Benzonase nuclease (Sigma).  Lin28-HIS6 was purified by Ni affinity 
chromatography followed by size-exclusion chromatography on a Superdex 75 
prep-grade column in 50 mM Tris-Cl pH 6.4, 200 mM NaCl, 5 mM BME. All 
purification steps were carried out on ice or at 4°C.   
 
Lin28-binding RNAs 
RNAs were synthesized by Integrated DNA Technologies (Coralville, IA) and 
obtained as a lyophilized powder. RNAs were reconstituted in 10 mM sodium 
phosphate buffer, pH 6.4, 100 mM KCl, 4 mM MgCl2. Annealing was carried out 
by heating the samples to 80°C for 10 minutes and allowing them to cool 
overnight to 20°C. 
RNA sequences: 
pre-let-7a-1 
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UGGGAUGAGGUAGUAGGUUGUAUAGUUUUAGGGUCACACCCACCACUGG
GAGAUAACUAUACAAUCUACUGUCUUUCCUA 
pre-let-7g 
AGGCUGAGGUAGUAGUUUGUACAGUUUGAGGGUCUAUGAUACCACCCGG
UACAGGAGAUAACUGUACAGGCCACUGCCUUGCCA 
let-7a-1 loop  
GGUUGUAUAGUUUUAGGGUCACACCCACCACUGGGAGAUAACUAUACAAU
CUA 
let-7d loop 
UUAGGGCAGGGAUUUUGCCCACAAGGAGGU 
let-7g loop 
GAGGGUCUAUGAUACCACCCGGUACAGGAG 
cel-pre-let-7 
UACACUGUGGAUCCGGUGAGGUAGUAGGUUGUAUAGUUUGGAAUAUUAC
CACCGGUGAACUAUGCAAUUUUCUACCUUACCGGAGACAGAACUCUUCGA 
DSG2 LRE 
GGUCUGCUAUGUGGGCAGAGG 
HSPA5 LRE 
GGCGUGAGGUAGAAAAGGCUAAGAGAGCCUUGUCUU 
SUN1 LRE 
UAUCCAGAAGGAGCUGGAAG 
OCT4 LRE 
GCAGAAGAGGAUCACCCUGGGAUAUACACAGGCCGAUGUGGGGCUCACC
CUGGGGGUUCUAUUUGGGAAGGUAUUCAGCCAAACGACCAUCUGCC 
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miR-21 loop 
GAUGUUGACUGUUGAAUCUCAUGGCAACAC 
 
Electrophoretic mobility shift analysis 
EMSAs were conducted using 2x105 cpm 32P-5ʼ-end-labeled RNA probes. 
Binding buffer contained 50 mM Tris (pH 7.6), 100 mM KCl, 5% glycerol, 40 units 
of RNAseOUT (Invitrogen) and 10 mM BME. Binding reactions were conducted 
in 20 µl with increasing amounts of recombinant Lin28-His6 (0, 0.15, 0.3, 0.6, 
1.25, 2.5, 5.0, 10 µM). Bound complexes were resolved on native 5% 
polyacrylamide gels and visualized by autoradiography. 
 
NMR spectroscopy 
NMR spectra were acquired on Bruker 500 MHz or 600 MHz spectrometers 
equipped with cryoprobes. 1D 1H NM spectra were acquired after annealing 200-
500 µM RNA in 10 mM sodium phosphate buffer, pH 6.4, 100 mM KCl, 4 mM 
MgCl2 in 90%H2O/10%D2O. Samples were equilibrated at 5°C. Data was 
accumulated with 1024 transients over a frequency width of 10.33 kHz with 32K 
data points. Spectra were processed using MestReNova.  2D NOESY spectra in 
H2O were acquired at mixing times from 80-200 ms at temperatures from 10°C 
°C -40°C. 2048 complex points were acquired in the indirect dimension and 1024 
free induction decay (FIDs) were accumulated in the direction dimension. A 
relaxation delay of 1.5 s was used for all experiments.  
 
N-methylmesoprphyrin IX (NMM) fluorescence assay 
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NMM was obtained from Frontier Scientific (Logan, UT). Fluorescence assays 
were performed in 30 µL of 10 mM sodium phosphate buffer, pH 6.4, 100 mM 
KCl, 4 mM MgCl2 and 5 µM NMM. The RNA concentration ranged from 0-250 
µM. All fluorescence experiments were preformed using a FlexStation III plate 
reader with excitation and emission wavelengths of 399 nm and 614 nm, 
respectively. Fluorescence measurements were repeated three times for each 
sample and the intensities averaged and corrected by running a buffer control 
without RNA before each series of experiments. Fluorescence intensities were 
normalized to the maximum intensity of UG4U. Results shown are the average of 
3-5 independent replicates. Error bars represent the standard deviation between 
experiments. 
 
G-score cumulative distribution plots 
Cumulative distribution plots were calculated using the G-scores per Kb 
generated by Quadruplex G-rich Sequence (QGRS) Mapper (18) for the 
indicated mRNA target lists.  A Kolmogorov-Smirnov (K-S) statistical test (40) 
was used to calculate p-values and determine how the G-score of each mRNA 
list compares against the random mRNA distribution.   
 
Unwinding assay 
Unwinding assays were carried out with constant amounts of let-7g loop or 
HSPA5 LRE (50 µM) in 10 mM sodium phosphate buffer, pH 6.4, 100 mM KCl, 4 
mM MgCl2 and 5 µM NMM to which rLin28A or BSA protein was added.  The 
protein concentration ranged from 0-6.25 µM.  After the addition of protein, 
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samples were allowed to equilibrate at least 4hrs at 4°C. Fluorescence intensities 
were recorded using a FlexStation III plate reader, as in the NMM fluorescence 
assay.  Protein only samples were recorded in 10 mM sodium phosphate buffer, 
pH 6.4, 100 mM KCl, 4 mM MgCl2 and 5 µM NMM without RNA. Fluorescence 
intensities were normalized to the maximum intensity without protein. Results 
shown are the mean value and standard deviation of 3 replicates. 
 
Competition EMSA 
Competition EMSAs were conducted using 2x105 cpm 32P-5ʼ-end-labeled let-7g 
loop or HSPA5 LRE probes and a constant rLin28A (10 µM). Competition 
reactions were conducted in the same EMSA binding buffer with increasing 
amounts of NMM (0, 1.5, 3, 6, 12.5, 25, 50, 100 µM). Bound complexes were 
resolved on native 5% polyacrylamide gels and visualized using autoradiography. 
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Chapter 3: Conclusions and Future Directions 
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Lin28 is an evolutionarily conserved RNA-binding protein that regulates cell 
differentiation (1, 2). It has been unclear how Lin28 identifies its target RNAs and 
distinguishes them from other RNAs. Although multiple RNA sequence motifs have 
been suggested to influence Lin28 binding to RNA, the motifs are small and abundant in 
the transcriptome. We hypothesized that Lin28 recognizes a common structural feature 
in its RNA targets.  To address this we compared the RNA structural features of Lin28 
binding-RNAs that contain many of the putative Lin28 binding sequence elements, 
including the pre-let-7 and the pre-let-7 terminal loops with the 3’GGAG motif, the LREs 
of DSG2, HSPA5 and SUN1, which contain the consensus sequences AAGNNG, 
AAGNG(N) and (N)UGUG(N), respectively, and the LRE of OCT4 which contains the “A 
bulge”.   
By 1D NMR spectroscopy we found that Lin28-binding RNAs contain imino 
resonances from 10-12.4 ppm, indicative of non-canonical hydrogen bonds (3-5).  The 
imino resonance pattern and thermostability of these resonances is characteristic of the 
G:G:G:G hydrogen bonding networks found in G-quartets (G4s) (3, 5, 6).  Despite 
tremendous efforts, we were unable to obtain high-resolution 2D NMR spectra that 
could provide further structural support.  G4-containing RNAs are known to be prone to 
aggregate (3, 7-9), which may have foiled our efforts.  In fact on native gels, the Lin28 
binding loops and LREs contained multiple bands that could not be eliminated by buffer 
changes.  Future structural studies of Lin28 complexed with a let-7 loop, LRE of an 
mRNA or GGA-containing G4 such as d(GGA)8  would be worthwhile.   
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G-quartets (G4s) are structures in which four guanines are interconnected by 
Hoogsteen base pairing.  Parallel-stacked G4s form unique structures known as G-
quadruplexes (3, 10, 11). Quadruplexes are found within DNAs corresponding to 
eukaryotic telomeres (12), the promoter regions of some oncogenes, including BCL-2 
(13), c-KIT (14), c-MYB (15), c-MYC (16), HIF1-α (17), hTERT (18), KRAS (19), Rb 
(20), and VEGF (21), immunoglobulin gene switch regions (22), and ribosomal genes 
(23). Although most studies have focused on DNA-G4s, RNA-G4s are attracting more 
attention as G4 structures have been identified in HIV RNA (24), at pre-mRNA cleavage 
sites (25) and within the UTRs of mRNAs where they influence translation (26, 27). An 
RNA G4 was identified within the Lin28 target IGF2, but outside its LRE (28). A 
structure of a Lin28-binding RNA is required to conclusively determine whether G4s are 
important determinants for Lin28 binding.  
Lin28-binding RNAs interact with the highly specific G4 fluorescent dye, N-methyl 
mesoporphryin IX (NMM) (29, 30). Lin28 RNA targets, but not control RNAs such as the 
loop of miR-21, induced NMM fluorescence. Mutations and truncations of Lin28 RNA 
targets that hindered Lin28 binding also led to decreased NMM fluorescence. These 
results suggest that Lin28 and NMM recognize a similar structure. Because NMM 
selectively binds only to G4s, Lin28 RNA targets likely contain G4 features that are 
critical for Lin28 recognition.  
Lin28-bound mRNAs are enriched for sequences with increased potential to form 
G4s. The Peng dataset of Lin28 targets contains 1,200 mRNAs that were enriched at 
least 2.5 fold in a Lin28 immunoprecipitation (IP), compared to a pre-immune control IP 
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in human embryonic stem cells (hESCs) (31). No significantly enriched sequence was 
identified within this list of Lin28 targets. However, we found that the top 50 most 
enriched Lin28 mRNAs from this dataset are highly enriched for sequences likely to 
form G4s. In addition, the top 50 Lin28 mRNA targets from the Hafner dataset of Lin28-
bound mRNAs identified by PAR-CLIP in FLAG/HA-Lin28-overexpressing HEK 293 
cells also were predicted to have an increased likelihood to form G4s.  The Hafner 
dataset contains 1,800 Lin28A mRNA targets. Although the authors proposed a AYYHY 
consensus sequence where Y is a pyrimidine and H is any nucleotide except guanine, 
they did observe that ~15% of the Lin28 targets were enriched for guanines (32). Based 
on binding assays they proposed Lin28 binds U-rich sequences. However, in every 
example they tested, the addition of GA-repeats to oligonucleotide sequences 
enhanced Lin28 binding. The increased potential to form G4s within multiple Lin28 
target datasets suggests that the G4 structure might be a unifying feature among all 
Lin28-binding RNAs. We did not analyze the potential to form G4s of Lin28 mRNA 
targets identified by the Wilbert and Cho studies (6,000 and 13,000 Lin28 bound 
mRNAs in human and mouse embryonic stem cells, respectively) (33, 34), because 
neither study ranked the Lin28-binding mRNAs.  
G-quadruplexes form diverse structures depending on the number of stacked 
G4s, strand orientation, loop structures and whether the G4s are formed via inter- or 
intramolecular interactions (10, 11). GGA-repetitive quadruplexes have been identified 
that form G-quartets and G:A pentads, hexads and heptads (35-38). Lin28 binds to 
d(GGA)8, which forms a mixed G-quartet-G:A heptad structure but not to all G4 nucleic 
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acids. GGA repeats are present in all of the Lin28 binding sequences and the 5’terminal 
28 nts of the LRE of HSPA is nearly identical to d(GGA)8. Moreover the structure of 
Lin28 bound to pre-let-7g loop sequences identified GGAG as an important motif for 
binding Lin28 ZnFs domains. These results may suggest that Lin28 recognizes 
specialized G4s containing GGA-repeats. The NMR data for the let-7a-loop and let-7g-
loop contained resonances characteristic of G-quartets and G:A or A:A mismatches. A 
GGA-repetitive G4 structure would explain these resonances. This type of G4 structure 
could unify some of the seemingly inconsistence Lin28-binding motifs described in the 
literature.  The 3’GGAG motif of pre-let-7s identified in the crystal structure of Lin28 
bound to pre-let-7 loop sequences could form essential components of the GGA-G4.  
Moreover the As and Gs enriched in the various Lin28 consensus sequences (GAGGA, 
AAGNNG, AAGNG(N), and (N)UGUG(N), where N is any nucleotide) and the proposed 
“A bulge” flanked by two G:Cs could be critical residues for the GGA-G4 type 
architecture. Future structural studies and binding assays with Lin28 and additional 
GGA-G4s will determine if Lin28 selectively binds GGA-G4s.   
Lin28 inhibits let-7 processing across the animal phylum (39).  Unlike mammalian 
let-7s, the terminal loop of C. elegans pre-let-7 lacks a 3’GGAG motif (39). Nucleotides 
that partially extend into the C. elegans let-7 stem bind to the ZnF domains of human 
Lin28 (40).   Here we showed that the C. elegans pre-let-7, which contains several GGA 
repeats, binds to NMM, suggesting it may form a G4 structure. This suggests that a G4 
structure might be an evolutionarily conserved mechanism for Lin28 recognition. 
 72 
Recent atomic structures of Lin28 in complex with fragments of pre-let-7 loop 
sequences did not detect G4s (40, 41). However, the structure of the free RNA may not 
be the same as that bound to Lin28.  Footprinting assays of pre-let-7g revealed that 
Lin28 binding induces a conformational change within the RNA (42). Isolated studies 
with the ZnF domains suggest they partially unfold pre-let-7 targets (43). Additionally, a 
FRET study revealed that the cold-shock domain (CSD) of Lin28 remodels the terminal 
loop of pre-let-7 by unwinding the upper stem region (44). We propose that Lin28 
“unwinding” RNA disrupts the G4 structure, since in the presence of Lin28 the Lin28-
binding RNAs no longer induce NMM fluorescence.  
Unwinding G4s could be essential for Lin28 function.  During let-7 biogenesis, 
Lin28 recruits TUT4 to pre-let-7 transcripts and then TUT4 uridylates pre-let-7s to 
promote their degradation (45, 46).  TUT4 does not bind to pre-let-7 in the absence of 
Lin28 (46). Unwinding of the pre-let-7 G4 by Lin28 could be required for the TUT4 
interaction and subsequent uridylation (Figure 3.1). Since the G4 structure might 
interfere with ribosome scanning, unwinding G4s in mRNAs could also explain Lin28’s 
ability to stimulate mRNA translation.  
G4 intercalating agents have been assessed for anti-cancer therapy (47-49). 
TMPyP4, a porphyrin analog of NMM that binds G4s and double-stranded DNA, blocks 
c-MYC transcription and decreases tumor growth and increases survival in tumor 
xenograft studies (47, 50). If unwinding G4s is crucial to Lin28 function, the G4 feature 
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Figure 3.1 Model for Lin28 RNA regulation. We propose that Lin28 binds and 
unwinds G4s in pre-let-7 miRNAs (A) and in LREs of mRNAs (B). Unwinding pre-let-7s 
might be required for TUT4 binding, subsequent uridylation and degradation of pre-let-
7s. Unwinding G4s in LREs may increase ribosome scanning and stimulate mRNA 
translation. The Lin28 CSD is in blue and the ZnFs are in green. 
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of Lin28-binding RNAs could represent a novel site to manipulate Lin28 activity. Here, 
we have shown that NMM inhibits Lin28 binding to RNAs in a gel shift. This is the first 
example of a small molecule inhibitor of Lin28. Future studies should investigate 
whether NMM or similar G4 intercalators can inhibit Lin28 function in cells.  Also, since 
d(GGA)8 is a DNA G4, it is worth investigating whether Lin28 might also recognize and 
regulate DNA G4-containing sequences.  
 
Summary of This Work: 
 
The work in Part 1 of this thesis identifies a previously unknown common structural 
feature of Lin28-regulated miRNAs and mRNAs. By NMR spectroscopy, fluorescence 
assays and bioinformatics we show that the pre-let-7s and the Lin28 responsive 
elements (LREs) of mRNAs contain G-quartet features (G4s). We propose G4s are 
unifying features among Lin28-binding RNAs. Our data suggest that Lin28 may 
specifically recognize GGA-containing planar G4-like structures. Lin28 binding unwinds 
G4s in its RNA targets. Our findings add new insight to understanding how Lin28 
selects and regulates its miRNA and mRNA targets. 
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Part 2: Using NMR as a tool for comparing differences in cellular metabolism 
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Chapter 4: N-acetylneuraminic acid is increased in tumor initiating cells and 
cytidine monophosphate N-acetylneuraminic acid synthetase is critical for tumor 
initiation 
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Abstract 
 
Using an unbiased NMR screening method, we sought to identify glucose metabolites 
that are differentially produced in the highly malignant breast cancer BPLER cell line, 
compared to the isogenic, but less aggressive, HMLER cell line. Using multi-
dimensional NMR experiments, and mass spectrometry we found that N-
acetylneuraminic acid (Neu5Ac) is ~7-fold more abundant in BPLER cells.  Neu5Ac is 
added as the terminal sugar to mucinous cell surface glycoproteins. Loss of Neu5Ac by 
enzymatic removal or siRNA knockdown of the Neu5Ac biosynthetic enzymes N-
acetylneuraminic acid synthase (NANS) and cytidine monophosphate N-
acetylneuraminic acid synthetase (CMAS) decreased the ability of BPLER cells to 
invade through a basement membrane. CMAS protein is much more abundant in 
BPLER than HMLER. Overexpressing CMAS in HMLER cells increases their malignant 
behavior. BPLER cells stably knocked down for CMAS no longer form tumors in mice. 
Thus, Neu5Ac is a glucose metabolite that is selectively enriched in BPLER and the 
expression of Neu5Ac biosynthetic enzyme CMAS is essential for BPLER’s ability to 
initiate tumors.  
 
Introduction 
 
 Metabolic reprogramming is essential for many cancers. To maintain a high 
proliferation rate, cancer cells must take up and metabolize nutrients from the 
environment to produce sufficient ATP to fuel cellular processes and for rapid 
proliferation (1, 2).  Complete oxidation of glucose into carbon dioxide via the oxidatitive 
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phosphorylation pathway generates ~36 molecules of ATP per glucose molecule (3). 
Cancer cells often do not rely on the oxidative phosphorylation pathway, but rather 
switch to glycolysis, the so called “the Warburg effect” (4).  Glycolysis generates lactate 
from glucose and produces only two molecules of ATP per glucose molecule (3). Rather 
than maximizing ATP output, cancer cells divert part of their glucose catabolism to 
biomass production (2, 5).  How glucose usage within cancer cells differs from that of 
normal cells is incompletely defined.  
 We used an unbiased NMR metabolite-profiling platform to follow the metabolic 
fate of glucose, comparing a highly malignant human triple negative breast cancer 
(TNBC) cell line (BPLER) with a less malignant isogenic line (HMLER) generated from 
the same donor. BPLER and HMLER cells were derived from the same primary breast 
tissue and transformed with identical genetic factors (hTERT, SV40 LT and hRASv12) 
(Figure 4.1) (6). BPLER cells were cultured in chemically defined WIT media and 
HMLER cells were cultured in MGEM media. BPLER cells have a high tumor initiating 
capacity.  Only 100 BPLER cells formed tumors after subcutaneously injected into the 
flanks of immunodeficient mice (6). However 1x106 HMLER cells are needed to form 
tumors (6). Based on their dramatic differences in malignancy we hypothesized that 
BPLER cells might utilize glucose differently.  We compared glucose metabolites in 
BPLER cells and HMLER cells as a way to uncover pathways that might be important 
for tumor initiation or malignancy of TNBC cells.  
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Figure 4.1 BPLER are more malignant than isogenic HMLER cells. (A) BPLER and 
HMLER cell lines were derived from the same normal breast tissue, cultured in different 
medium (WIT or MGEM) and transformed with identical factors (hTERT, SV-40 LT and 
H-ras-v12). Figure from Ince, T., et al (2007). (B) BPLER cells are more malignant than 
HMLER cells. Only 100 BPLER cells injected subcutaneously into the flanks of 
immunocompromised mice formed tumors, whereas 1x106 HMLER cells were needed 
to form tumors (6).  
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Results  
Highly tumorigenic BPLER cells and less aggressive HMLER cells differentially 
catabolize glucose. 
To compare glucose metabolites generated in BPLER and HMLER cells, we 
used unbiased NMR metabolite profiling (Figure 4.2). BPLER and HMLER cells, 
cultured in WIT media, were transferred to glucose-free media for ~30 mins before 
adding uniformly labeled 13C-glucose. Cells were incubated for ~2 hours to allow 
glucose uptake and catabolism. To assess the 13C background, the spectra of equal 
numbers of cells that were not incubated with 13C-glucose were also measured.  For 
each cell line, water-soluble metabolites were isolated using chloroform extraction and 
ultracentrifugation. The aqueous layer was collected and lyophilized. Water-soluble 
metabolites from ~15 million cells were resuspended in ultra-pure D2O. For referencing 
in the NMR analysis, 1mM of 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) was 
added to each sample.  
Glucose metabolites were analyzed by 13C-1H heteronuclear single quantum 
coherence spectroscopy (HSQC). Resonances in HSQC spectra are detected for all 
13C-nuclei that are attached to a unique proton (7). The HSQC spectra for BPLER and 
HMLER cells cultured with 13C-glucose had several well-resolved intense peaks (Figure 
4.3). Replicate samples showed identical resonances. No resonances were observed in 
the HSQC spectra of unlabeled samples, suggesting that at this low cellular 
concentration there is little 13C-background.  Thus, the 13C-signal in the HSQC spectra 
from BPLER and HMLER cells incubated with 13C-glucose are metabolite resonances 
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Figure 4.2 Unbiased NMR metabolite profiling workflow. Equal numbers of BPLER 
and HMLER cells were grown in WIT medium then incubated in glucose-free media. 
After ~30 min, 13C-glucose was added to to the media and cells were incubated for ~2 
hrs. Aqueous and organic metabolites were separated. Water-soluble metabolites were 
resuspended in D2O with 1mM 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS). 
Differential metabolites were identified by comparing resonances in BPLER and HMLER 
13C-1H HSQC spectra.  
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Figure 4.3 13C-1H HSQC metabolite spectra of BPLER and HMLER cells. 
Representative 13C-1H HSQC spectra for ~15 million BPLER (A) and HMLER (B) cells 
supplemented with 13C-glucose. Metabolite resonance peaks correspond to 13C nuclei 
attached to unique protons. 
 89 
derived from the 13C-glucose added to cells (Figure 4.3).  By overlaying the HSQC 
spectra from BPLER and HMLER cells we found that the intensity and expression of 
some metabolite resonances differed between the cell types (Figure 4.4). Although 
many resonances varied in intensity, we decided to focus on the 9 resonances that 
were unique to BPLER.   
 
N-acetylneuraminic acid is increased in BPLER cells 
To identify the metabolite(s) that correspond to the resonances upregulated in 
BPLER cells, we queried the Human Metabolome database (HMDB). The HMDB 
contains reference NMR information for more than 7,000 detected metabolites (8, 9). 
For 8 of the 9 13C-1H frequencies uniquely dected in BPLER cells, known metabolites 
contain similar resonance frequencies (Table 4.1). Six of these resonances are found in 
N-acetylneuraminic acid (Neu5Ac) (Figure 4.5). To verify this assignment the 13C-1H 
HSQC reference spectrum of pure Neu5Ac was downloaded from the HMBD and 
compared to the BPLER and HMLER spectra (Figure 4.6).  Indeed all of the Neu5Ac 
resonances overlap with resonances specifically increased in the BPLER spectra.  This 
strongly suggests that the differential resonances correspond to Neu5Ac, and that 
BPLER have increased Neu5Ac.   To validate this assignment further, we used liquid 
chromatography mass spectrometry (LC-M/S). Neu5Ac was used as a standard to 
determine retention time. BPLER and HMLER water-soluble metabolite extracts were 
analyzed for Neu5Ac abundance using multiple reaction monitoring (MRM) for two 
fragments of Neu5Ac. Neu5Ac was ~7-fold more abundant in BPLER cells than in 
 90 
 
Figure 4.4 BPLER and HMLER show differential production of glucose 
metabolites.  Overlay of 13C-1H spectra for BPLER (red) and HMLER (blue) cells 
indicated the intensity and expression of metabolite resonances differed between cell 
types (A). Close up of the boxed region highlights resonances with increased intensity in 
BPLER cells (red) (B). 
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Table 4.1 Metabolite resonances enriched in BPLER cells. 13C-1H resonance 
frequencies detected in BPLER but not in HMLER cells. Potential differentially produced 
metabolites were identified by searching reference compounds in the Human 
Metabolome Database with similar resonance frequencies. Chemical shift tolerances of 
+/- 0.05 ppm and +/- 0.1 ppm  were allowed in the 1H and 13C dimension respectively. 
N-acetylneuraminic acid (red) has resonances at the same frequency as 6 of the 9 
BPLER-specific peaks and its precursors N-acetyl-D-mannosamine and uridine 5’-
diphospho-N-acetylglucosamine may correspond to another peak (bold). 
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Figure 4.5  Structure of N-acetylneuraminic acid (Neu5Ac). N-acetylneuraminic acid 
(Neu5Ac) was identified as a putative metabolite that might have many of the differential 
resonances observed in the BPLER spectra. 
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Figure 4.6 Neu5Ac resonances overlap with the differential resonances of BPLER 
cells. Overlay of a 13C-1H HSQC reference spectrum of pure Neu5Ac (green) with 
HSQC spectra of BPLER cells (red) and HMLER cells (blue). Neu5Ac resonances that 
overlap with the differentially expressed resonances of BPLER cells are denoted by 
green circles. 
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HMLER cells (Figure 4.7). The NMR and M/S results confirmed that Neu5Ac generation 
is increased in BPLER cells.  
 
BPLER cells have increased Neu5Ac on cell surface glycoproteins 
Neu5Ac is the most abundant member of the sialic acid family of sugars (10). 
Sialic acids primarily exist as terminating residues on glycosylation chains of cell 
surface glycoproteins (11). Increased sialic acid levels are associated with metastasis 
(12-14). The mechanism that leads to increased sialic acid expression remains unclear 
(15).  
Neu5Ac is generated through the hexosamine pathway, where multiple enzymes 
convert glucose to UDP-N-acetylglucosamine (UDP-GlcNAc) (10). UDP-GlcNAc is the 
common precursor for all amino sugars of glycoproteins, lipids and proteoglycans. UDP-
GlcNAc was also one of the potential metabolites detected only in BPLER cells (Table 
4.1). UDP-GlcNAc is then converted to Neu5Ac by sequential action of enzymes 
glucosamine (UDP-N-acetyl)-2-epimerase (GNE), N-acetylneuraminic acid synthase 
(NANS) and N-acetylneuraminic acid phosphatase (NANP) (16, 17). Neu5Ac is then 
activated by the enzyme cytidine-5-monophosphate N-acetylneuraminic acid synthetase 
(CMAS) into cytidine-5-monosphosphate N-acetylneuraminic acid (CMP-Neu5Ac), 
which is transported to the Golgi. In the Golgi sialyltransferases (STs) catalyze the 
transfer of Neu5Ac onto terminal residues of glycoproteins and glycolipids (Figure 4.8).  
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Figure 4.7 Neu5Ac is more abundant in BPLER cells. LC-M/S multiple reaction 
monitoring (MRM) for two fragments of Neu5Ac demonstrated that Neu5Ac is ~7-fold 
more abundant in BPLER cells than in HMLER cells. Values are reported as area under 
the Neu5Ac peak compared to a standard spike-in control of  2-ketobutryic acid (2-KB).  
Shown are the average values and standard deviation for three replicates. Performed 
with Colin Hill at Agios Pharmaceutical.  
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Figure 4.8 Neu5Ac biosynthetic pathway (Continued).  
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Figure 4.8 Neu5Ac biosynthetic pathway (Continued). In the cytosol glucose is 
converted to glucose-6-phosphate (glucose-6-P) by hexokinase 1 (HK1). 
Phosphoglucose isomerase (PGI) converts glucose-6-P into fructose-6-phosphate 
(fructose-6-P). Utilizing glutamine, glucosamine-fructose-6-phosphate aminotransferase 
(GFA) next generates glucosamine-6-phosphate (GlcN-6-P). In an acetyl-CoA 
dependent manner glucosamine-6-P-N-acetyltransferase (GNA1) generates N-
acetylglucosamine-6-phosphate (GlcNAc-6-P). Phospho-acetyl-glucosamine mutase 
(PGM3) produces N-acetylglucosamine-1-phosphate (GlcNAc-1-P). Utilizing UTP, UDP-
N-acetylglucosamine pyrophosphorylase (UAP) generates UDP-N-acetylglucosamine 
(UDP-GlcNAc). In two steps glucosamine (UDP-N-acetyl)-2-epimerase (GNE) converts 
UDP-GlcNAc to N-acetyl-D-mannosamine (ManNAc) then to N-acetyl-D-mannosamine-
6-phosphate (ManNAc-6-P). N-acetylneuraminic acid synthase (NANS) adds 
phosphoenolpyruvate (PEP) to ManNAc-6-P to generate N-acetylneuraminic acid-9-
phosphate (Neu5Ac-9-P). N-acetylneuraminic acid phosphatase (NANP) removes the 
phosphate to produce N-acetylneuraminic acid (Neu5Ac).  In the nucleus, cytidine 
monophosphate N-acetylneuraminic acid synthase (CMAS) activates Neu5Ac to 
cytidine monophosphate N-acetylneuraminic acid (CMP-Neu5Ac). In the Golgi, 
sialyltransferases (STs) utilize CMP-Neu5Ac to attach Neu5Ac onto terminating 
residues of glycoproteins. 
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Increased Neu5Ac in BPLER could suggest increased sialylation on BPLER cell surface 
glycoproteins. To examine this we used wheat-germ-agglutinin (WGA) binding and 
fluorescence microscopy. WGA binds to Neu5Ac residues on glycoproteins (18). 
Therefore we incubated BPLER and HMLER cells with rhodamine-labeled WGA and 
compared the amount of rhodamine fluorescence in each cell line (Figure 4.9). BPLER 
cells had increased fluorescence. This may suggest that WGA more readily binds to 
BPLER cells. Since WGA binds Neu5Ac residues, it is likely BPLER cells are more 
heavily sialylated.  
 
N-acetylneuraminic acid expression correlates with invasiveness. 
Since Neu5Ac has previously been linked to metastasis (12-14) we hypothesized 
that increased Neu5Ac levels might contribute to invasiveness of BPLER cells. To test 
this hypothesis, we preformed invasion assays. In these assays cells are seeded in an 
upper chamber and the number of invading cells that penetrate through a matrigel-
coated 0.8 µm porous basement membrane into a lower chamber are monitored.  
Invading cells in the lower chamber are visualized by crystal violet staining and counted. 
Approximately 5-fold more BPLER cells invaded through the membrane than HMLER 
cells (Figure 4.10).  This is consistent with the increased malignancy of BPLER cells 
(6). Neuraminidase specifically removes α2-3, α2-6, and α2-8 linked Neu5Ac residues 
from cell surface glycoproteins (10).  Treating BPLER cells with 2 units of 
neuraminidase completely abolished their ability to invade (Figure 4.10). This suggests 
that Neu5Ac residues on glycoproteins contribute to BPLER invasiveness.  
 99 
 
 
Figure 4.9 Neu5Ac is more abundant on BPLER cell-surface glycoproteins. 
BPLER and HMLER cells were grown on coverslips and incubated with rhodamine-
labeled wheat-germ-agglutinin (WGA). WGA binds Neu5Ac residues on glycoproteins 
(18).  Rhodamine staining was measured using fluorescence microscopy. 
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Figure 4.10 Invasiveness of BPLER and HMLER cells correlates with Neu5Ac 
expression. (A-B) Representative images of the number of invading BPLER and 
HMLER cells (A) and BPLER and HMLER cells treated with 2 units of neuraminidase 
(B) that penetrated  a 0.8 µm porous basement membrane overlaid with matrigel. Cells 
were stained with crystal violet. (C) The average number of invading cells and the 
standard deviation for 3 replicate experiments are shown.  
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Neuraminidase treatment only marginally decreased the ability of HMLER cells to 
invade.  
 
CMAS expression is increased in BPLER cells 
Increased Neu5Ac in BPLER relative to HMLER could be due to increased 
Neu5Ac biosynthesis in BPLER cells. To begin to examine this possibility we compared 
the expression of two of the enzymes required for its biosynthesis, NANS and CMAS. 
There was no significant difference in NANS or CMAS mRNAs in BPLER compared to 
HMLER (data not shown). NANS protein levels by western blot also were comparable 
(Figure 4.11). However CMAS protein was readily detected by western blot only in 
BPLER. CMAS was also readily detected in another aggressive TNBC cell line MB468. 
 
Neu5Ac biosynthetic enzymes, NANS and CMAS, contribute to BPLER cell 
invasiveness 
We next sought to determine if Neu5Ac biosynthetic enzymes NANS and CMAS 
contribute to the malignant phenotype of BPLER cells. NANS catalyzes the 
condensation of N-acetylmannosamine (ManNAc-6-P) and phosphoenolpyruvate (PEP) 
into N-acetylneuraminic acid-9-phosphate (Neu5Ac-9-P) (Figure 4.8). ManNAc-6-P was 
also one of the potential metabolites only detected in BPLER cells (Table 4.1). CMAS 
activates Neu5Ac to CMP-Neu5Ac, which is required for transfer of Neu5Ac onto 
glycoproteins. To evaluate the contribution of Neu5Ac biosynthesis to invasivity, we 
transfected BPLER and HMLER with siRNAs against NANS (siNANS) and CMAS  
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Figure 4.11 CMAS protein is more abundant in BPLER cells. Immunoblots for NANS 
and CMAS. Knockdown by siRNAs was effective.Tubulin was probed as a loading 
control.   
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(siCMAS). Near complete knockdown of both proteins was observed  (Figure 4.11). 
Knockdown of either gene had little effect on BPLER proliferation as assessed by 
counting live cells 3 days after transfection with siNANS, siCMAS or a control siRNA 
(siControl) (Figure 4.12).  
When the invasion assays were preformed using BPLER cells treated with 
siControl, siNANS or siCMAS, knockdown of either CMAS or NANS profoundly inhibited 
invasion (Figure 4.13). Thus, NANS and CMAS play an important role in promoting 
BPLER cell invasion. Of note, adding Neu5Ac to the cell medium partially restored 
invasivity.  
 
CMAS expression correlates with invasion and tumor initiation 
To explore further the role of CMAS in invasion, we transfected the less invasive 
HMLER cells which had undetectable CMAS protein, with a plasmid overexpressing 
CMAS and repeated the invasion assay. There was a 8-fold increase in invading 
HMLER cells transfected to overexpress CMAS as compared to wild-type HMLER cells 
or HMLER cells expressing a control plasmid (Figure 4.14). Thus, increased CMAS 
enhances invasion.   
 
Stable knockdown of CMAS inhibits tumor initiation 
We next assessed whether CMAS expression was needed for BPLER tumor 
initiation. BPLER cells were infected with lentiviral vectors expressing a short hairpin 
RNA (shRNA) against CMAS (BPLER-shCMAS) or an empty vector (BPLER-EV).  
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Figure 4.12 siRNA knockdown of NANS and CMAS does not substantially affect  
BPLER cell viability. BPLER cell numbers were assessed by CellTiterGlo assay 3 
days after transfection with a non-targeting siRNA (siControl) or siRNAs against NANS 
(siNANS) and CMAS (siCMAS). Knockdown of the cell cycle regulator PLK1 (siPLK1) 
was used as a positive control. Cell numbers were normalized to mock treated cells. 
Shown are average and standard deviation for 3 replicate experiments.  
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Figure 4.13 NANS and CMAS expression are needed for BPLER invasiveness. (A) 
Representative images of invading BPLER cells after transfection with control siRNA 
(siControl) or siRNAs against NANS (siNANS) or CMAS (siCMAS). In some cells 125 
µM was Neu5Ac added to the medium.  (B) Average number of invading cells in each 
condition and standard deviation for 3 experimental replicates are shown.  
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Figure 4.14 Overexpressing CMAS in HMLER cells increases migration. (A) 
Representative images of the number of invading HMLER cells and HMLER cells 
transfected with a control plasmid or a plasmid overexpressing CMAS that penetrate the 
matrigel coated 0.8 µm porous basement membrane.  Cells were stained with crystal 
violet.  (B) The average number of migrating cells and standard deviation of three 
replicate experiments are shown.     
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The lentiviral vectors contained a RFP selection marker, which was used to sort cells 
that contained the integrated vector. BPLER-shCMAS cells had 90% less CMAS than 
BPLER-EV cells by qRT-PCR (Figure 4.15A). No CMAS protein was detected in 
BPLER-shCMAS cells by immunoblot (Figure 4.15B).  
5x105 BPLER-shCMAS or BPLER-EV cells were injected subcutaneously into 
the flanks of 4-week old NOD/SCID/IL2Rγ-/- mice (N=4/group). Every 3 days tumor size 
was monitored (Figure 4.16). After ~60 days, the BPLER-EV tumors exceeded 15 mm 
in diameter and the mice were sacrificed. During this same time period, no palpable 
tumors were detected in mice injected with BPLER-shCMAS cells. This suggests that 
CMAS expression is critical for tumorigenesis.  
 
Discussion 
 
The metabolic output of a cell is influenced by the functional genomic, 
transcriptomic and proteomic networks that define that cell type. Several analytical 
techniques are available to profile metabolites including mass-spectrometry (M/S), 
chromatography and NMR spectroscopy. From small amounts of starting material M/S 
and chromatography can provide absolute quantification of metabolites. However in 
most cases the metabolites of interest must be selected a priori.  Untargeted M/S 
approaches typically involve multiple rounds of purification and identification steps. 
NMR has the advantage that it can provide global and unbiased metabolite structural 
information. However, NMR is much less sensitive and generally requires increased  
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Figure 4.15 BPLER-shCMAS cells have decreased CMAS expression. (A). qRT-
PCR and (B) western blot to compare CMAS mRNA and protein respectively. BPLER-
shCMAS cells had decreased CMAS expression.    
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Figure 4.16 CMAS expression is required for tumor initiation. 5x105 BPLER-EV or 
BPLER-shCMAS cells were injected subcutaneously into the flanks of 4-week old 
NOD/SCID/IL2Rγnull mice (N=4/group).  (A) tumor size was recorded every 3 days.  The 
average tumor volume and standard deviation for each group of mice are shown. (B) 
Tumors from BPLER-EV injected mice exceeded 15 mm in diameter by day 60 and the 
mice were sacrificed. The tumors are shown. No palpable tumors were detected in mice 
injected with BPLER-shCMAS cells during this time period. 
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sample amounts. This can be incredibly burdensome, especially for 2D NMR 
experiments that rely on 1.1% 13C natural abundance. 
 Here we utilized an unbiased NMR metabolite-screening platform to specifically 
follow glucose catabolism in the highly tumorigenic BPLER cell line and compare it to 
glucose products in the less aggressive HMLER cell line.  Instead of using large sample 
amounts we used relatively few cells (~15 million) fed with 13C-glucose. With these 
conditions, background 13C was negligible and we could follow the products of the 13C-
labeled tracer.  We recorded 13C-1H HSQC spectra to uncover the glucose metabolites 
in BPLER and HMLER cell lines.  By comparing spectra we observed that most 
resonances agreed but a small number of metabolite resonances varied between the 
cell lines suggesting that BPLER and HMLER cells differentially catabolize glucose.  
Nine metabolite resonances were only detected in BPLER cells, a similar number 
were unique to HMLER cells. Some resonances were detected in both BPLER and 
HMLER cells but with different intensities. To gain a complete understanding of the 
metabolic pathways in these cells, future work could examine all of these differences.  
However, here we focused on the metabolite resonances unique to BPLER cells. We 
matched these resonance with reference compounds in the Human Metabolome 
Database (HMBD), which identified N-acetylneuraminic acid (Neu5Ac) as a potential 
metabolite enriched in BPLER cells. All the resonances in the reference 13C-1H HSQC 
spectra of Neu5Ac corresponded to resonances only detected in BPLER cells. LC-M/S 
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analysis further confirmed that Neu5Ac is ~7-fold more abundant in BPLER cells as 
compared to HMLER cells. 
Neu5Ac is the most abundant sialic acid family sugar that is added as the 
terminal residue to some cell surface glycoproteins (10, 11, 19, 20). Neu5Ac expression 
confers mucinous properties to epithelial cell surfaces, providing a lubricant that makes 
them “slimy” and interferes with adhesion (14, 21, 22). Perhaps it should not be 
surprising that cells with more Neu5Ac have a more sialylated surface and be more 
invasive. In fact we found that BPLER were much more heavily sialyated than HMLER 
by staining with wheat germ agglutinin. Sialylation mediates numerous biological 
processes including masking antigenic determinates (23, 24), and altering cell-cell 
recognition, cell-contact inhibition (25), and cellular migration (10, 26). Increased 
Neu5Ac has been observed in many metastatic tumors (12-14, 27).  Consistent with the 
literature, we observed Neu5Ac expression correlated with cellular invasiveness. Using 
invasion assays we showed that more BPLER cells invaded through a 0.8 µm porous 
membrane overlaid with matrigel as compared to HMLER cells.  The ability of highly 
malignant BPLER cells to invade through the membrane was lost after neuraminidase 
treatment. Neuraminidase treatment only slightly reduced the ability of HMLER cells to 
invade. HMLER cells produce much less Neu5Ac and have much less surface 
sialylation. Identifying BPLER-specific Neu5Ac containing proteins in the future may 
pinpoint specific glycoproteins that are critical for tumor initiation and metastasis.   
siRNA knockdown of the Neu5Ac biosynthetic enzymes NANS and CMAS 
drastically reduced the number of invading BPLER cells. Addition of Neu5Ac to the cell 
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medium partially restored invasion. The mechanism by which Neu5Ac rescues 
migration is unclear. One possibility is that sialyltransferases in serum catalyzed the 
addition of Neu5Ac onto cell surface proteins.  
CMAS protein expression was markedly increased in 2 highly tumorigenic 
BPLER and MB468 epithelial TNBC cell lines. Because TNBC cell lines and tumors are 
very heterogeneous, we are currently assessing CMAS mRNA and protein expression 
to determine if this is a common feature of epithelial TNBC cell lines.  Overexpressing 
CMAS in HMLER cells increased their invasiveness. Reciprocally BPLER cells with 
stably knocked down CMAS were unable to form tumors in mice.  These results suggest 
that CMAS is a critical regulator of invasion and tumor initiation in BPLER. It will be 
worthwhile to determine if CMAS expression is required for tumor formation and 
invasion for other TNBCs.  We also plan to investigate in the future whether CMAS 
overexpression enhances tumor formation by HMLER cells.  
CMAS is expressed in both eukaryotic and prokaryotic organisms (28). CMAS 
catalyzes the conversion of Neu5Ac to CMP-Neu5Ac. This activation step is required to 
transfer Neu5Ac to glycoproteins. In pathogenic bacteria CMAS is a virulence factor 
catalyzing the production of sialylated proteins that mimic host proteins (28, 29).  In 
humans, a prominent role of CMAS in cancer development has never before been 
noted. A single report, using cancer-specific high-throughput annotation of somatic 
mutations (CHASM), identified genetic mutations in 18 genes including CMAS important 
for pancreatic cancer (30). No functional studies were performed. Our findings suggest 
that CMAS expression is essential for tumor initiation. Thus CMAS could be a novel 
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therapeutic target for some breast cancers. The crystal structure of the catalytic domain 
of murine CMAS has been resolved to 2.8 Å (31). This could serve as the starting point 
for rational drug design of CMAS inhibitors. 
 
Summary of this work 
In part 2 of this thesis we used an unbiased NMR metabolite screening method to 
identify glucose metabolites differentially produced in BPLER and HMLER isogenic 
triple negative breast cancer cell lines that have dramatic differences in tumor initiating 
capacity. N-acetylneuraminic acid (Neu5Ac) a terminating sugar of many glycoproteins 
is much more abundant in BPLER than in HMLER cells. Manipulating Neu5Ac 
expression by enzymatic removal or knockdown of biosynthetic enzyme N-
acetylneuraminic acid synthase (NANS) and cytidine monophosphate N-
acetyneuraminic acid synthetase (CMAS) reduces in vitro invasivity of BPLER cells. 
CMAS is increased in BPLER cells. Overexpressing CMAS in HMLER cells increases 
their invasiveness. Stable knockdown of CMAS blocks BPLER tumor growth in mice. 
From our results we demonstrated increased Neu5Ac and CMAS expression is linked to 
tumor initiation and invasivity in a human triple negative breast cancer cell line.  
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Materials & Methods: 
Cell culture  
BPLER and HMLER cells were provided by R. Weinberg and Tan Ince and grown in 
WIT medium (Stemgent). MB468 cells were obtained from ATCC and grown in DMEM 
supplemented with 10% FBS.  For all transfections BPLER cells were reverse-
transfected with 50 nM siRNA using Dharmafect#1 (Dharmacon) in WIT medium. 
siGenome Smartpool siRNAs for human NANS (M-013399) and CMAS (M-009780) and 
Non-Targeting siRNA #1 (D-001210) were obtained from Thermo Scientific (Waltham, 
MA).  
 
NMR sample preparation 
For labeling experiments, 1.5x107 BPLER and HMLER cells were grown in WIT 
medium.  Cells were washed twice with warm PBS and then incubated in OPTIMEM 
medium without glucose for ~30 min.  Unlabeled or uniformly labeled 13C-glucose 
(Cambridge Isotope Laboratories, Cambridge, MA) was added directly to the medium 
and cells were incubated an additional ~2 hrs.  Cells were wash twice with PBS, 
trypsinized with Tryple Express (Invitrogen), and counted using Trypan blue staining. 
Equal numbers of cells were harvested by centrifugation at 500 x g for 5 min.  Cell 
pellets were immediately flash frozen in liquid nitrogen and stored at -80°C until ready 
for analysis. Cell pellets were thawed on ice and lysed by the addition of ice cold 
methanol and vortexed vigorously. Equal parts chloroform and water were added to the 
extract and vortexed vigorously. Extracts were incubated overnight at -20°C for phase 
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separation. The extract mixture was centrifuged at 10,000 x g for 40 min to complete 
phase separation and separate macromolecules. After centrifugation three layers were 
visible. The bottom phase contained organic metabolites. The interphase layer (white 
clumps) contained proteins and macromolecules. The top 2/3 water:methanol layer 
contained water soluble metabolites.  The top layer was collected and methanol was 
removed under vacuum. The water metabolites were flash frozen with liquid nitrogen 
and lyophilized. The completely dried samples were resuspended in 250 µL D2O 
containing 1 mM 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) standard (Cambridge 
Isotope Laboratories).  Samples were run in Shigemi tubes (Bruker).  
 
NMR spectroscopy 
The NMR spectra were collected on a Bruker 500 MHz spectrometer equipped with a 
cryoprobe. 2D 13C-1H HSQC spectra were collected with a relaxation delay of 1 s. A 
total of 2048 points with a spectral width of 4734.9 Hz and 13834.3 Hz were collected in 
the 1H and 13C dimensions respectively with 128 data points.  NMR data were 
processed using NMRPipe and Sparky (T.D. Goddard and D.G. Kneller, SPARKY3, 
University of California, San Francisco) to identify chemical shift resonances. Spectra 
were aligned and intensities scaled using resonances from the 1 mM DSS control.  
 
LC-Mass spectrometry 
Standards of N-acetylneuraminic acid (Neu5Ac) were used to optimize chromatography 
and determine retention time using a Waters Acquit UPLC coupled to an AbSciex-4000 
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mass spectrometer operating in the negative mode. Reverse phase chromatography 
was performed using a Waters Acquity HSS T3 2.1x50 mm column with 1.8 micron 
particle size with mobile phase A of 15 mM acetic acid, 10 mM tributylamine, 5% 
methanol and mobile phase B of 100% methanol. Neu5Ac was detected using multiple 
reaction monitoring (MRM) for fragments 307.987 and 307.9170.  2-ketobutyric acid (1 
µg/mL) was used as an injection standard. 3x105 BPLER and HMLER water-soluble 
metabolites were prepared as for the NMR samples. Dried metabolites were dissolved 
in 1 mL HPLC-grade water. Neu5Ac levels were measured using 10 µL injections.     
 
Fluorescence microscopy 
10,000 BPLER and HMLER cells were grown on glass cover slips, washed with warm 
PBS and fixed with 4% paraformaldehyde (PFA) for 20 min at room temperature. Cells 
were washed twice and incubated with rhodamine-labeled wheat germ aggultinin 
(WGA) (Vector Laboratories, Burlingame, CA) in PBS at a 1:1000 dilution for 10 mins.  
Cells were washed 5 times with PBS then mounted onto slides. Images were acquired 
using a Zeiss Axiovert 200M fluorescent microscope.  
 
Invasion Assays 
Cells were trypsinized and added (1.25x105 cells/well) in WIT medium to three wells of 
BD BioCoatTM Matrigel Invasion Chambers (BD Bioscience). WIT medium containing 
10% FCS was added to the lower chamber.  The invasion chambers were processed 24 
hrs later as per the manufacturer’s protocols. Invading cells were stained with crystal 
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violet.  Five random fields from each of the triplicate invasion assays were counted 
using phase contrast microscopy. 
 
Neuraminidase treatment 
As for the invasion assays, cells were trypsinized and added (1.25x105 cells/well) in 
WIT medium to three wells of BD BioCoatTM Matrigel Invasion Chambers (BD 
Bioscience) with 2 units of neuraminidase (New England Biolabs). The number of 
invading cells were stained with crystal violet and processed as for the invasion assays.  
 
Cell viability 
Cell viability was assessed using a CellTiterGlo kit (Promega) according to the 
manufacturer’s protocol. Chemiluminescence was measured using a BioTek Synergy2 
plate reader.   
 
RNA analysis 
Total RNA was extracted with Trizol (Invitrogen) and cDNA prepared from 1 µg total 
RNA using Thermoscript RT kit (Invitrogen) as per the manufacturer’s instructions. 2.5 
µl of diluted cDNA (1:20) was used as template for qPCR using Power Sybr-Green 
Master Mix (Applied Biosystems) and Biorad C1000 Thermal Cycler (Biorad). Relative 
CT values were normalized to  β-actin and converted to a linear scale using the –ΔCT 
method. 
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Western blot  
 Protein lysates were prepared using RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% 
sodium deoxycholate, 0.1% SDS, 50 mM Tris pH 8.0, containing Complete Mini-
protease Inhibitor Cocktail (Roche)). Protein concentration was determined using the 
BioRad DC protein assay kit (BioRad) and samples were resolved on 10% SDS-PAGE 
gels and transferred using a Transblot semi-dry transfer apparatus (BioRad).  Blots 
were probed with antibodies to NANS (Abcam mouse pAb ab88899), CMAS (Abcam 
mouse mAb ab57454) and α-Tubulin (Sigma mouse mAb clone B-5-1-2). Antibodies 
were diluted in 5% milk in TBS-T and incubated overnight at 4°C. Secondary mouse 
HRP-conjugated antibodies were from Amersham.  Protein signal was detected using 
the ECL Plus kit (Amersham).  
 
Stably knocked down cell lines 
To generate cells with stably knocked down CMAS we used a modified pGreenPuro 
lentiviral vector (System Biosystems, Mountain, CA) in which GFP was replaced with 
RFP (pRFPpuro) vector. Oligos containing the CMAS siRNA sequence (5’-
GTGTATGGGTTTCGACAGA-3’) and the complementary sequence (anti-sense CMAS) 
were synthesized into a short-hairpin RNA as (GATCC-siCMAS-CTTCCTGTCAGA-anti-
senseCMAS-TTTTTG). Oligos were annealed and ligated into pRFPpuro. Resulting 
plasmids were verified by sequencing and used to transfect HEK293T packaging cells 
to generate lentivirus.  Expression of RFP were used to sort cells by flow cytometry 
(FACSAria, Beckton Dickinson). After two rounds of sorting, we obtained a nearly 
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homogenous cell line stably knocked down for CMAS. RNA and protein expression 
were reduced by >90% as verified by qRT-PCR and immunoblot.  
 
Tumor models 
All animal procedures were performed with IACUC approval. Exponentially growing 
cells were trypsinized with Tryple Express (Invitrogen) and 5x105 cells were 
resuspended in a 1:1 WIT-matrigel solution and injected subcutaneously in the flanks of 
4-week old NOD/SCID/IL2Rγ-/- mice. Mice were palpated for tumor formation and tumor 
size was measured every 3 days by caliper.  Tumor volumes were calculated as 
Volume (µL)=L x W2 X 0.4. Mice were sacrificed when the tumor size exceeded 15 mm 
in diameter.   
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